Eczema, psoriasis, skin cancers and other skin disorders

Published on 02/03/2015 by admin

Filed under Internal Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2341 times

Chapter 14 Eczema, psoriasis, skin cancers and other skin disorder

Introduction

The integument (the skin) is the largest and heaviest organ in the human body consisting of approximately 16% of body weight and is the primary interface between the internal environment and the outside surroundings.1 Given that the thickness of skin has an extremely thin foundation, the epidermis protects animals against major environmental stresses, such as water loss and microorganism infection. Hence, the skin’s primary function is to act as a barrier to protect the body from damage caused by outside forces, contaminants, microorganisms and radiation exposure.

The skin epidermis and its appendages undergo ongoing renewal by a process called homeostasis. Stem cells in the epidermis have a crucial role in maintaining tissue homeostasis by providing replacement cells to those that are constantly lost during tissue turnover or following traumatic injury. A number of different skin stem cell pools contribute to the maintenance and repair of the various epidermal tissues of the skin. These include the inter-follicular epidermis, hair follicles and sebaceous glands. It is interesting to note that the basic mechanisms and signalling pathways that orchestrate epithelial morphogenesis in the skin are reused during adult life to regulate skin homeostasis.2

In clinical practice, dermatology includes about 3000 diseases that affect the skin and its accessory tissues (e.g. hair and nails).3 While many infamous epidemics with prominent skin manifestations such as small pox, plague, leprosy, and anthrax, have been largely controlled,4 other dermatologic diseases such as warts, acne, and dermatitis remain especially common.

In 2004, more than 50% (165 million) of the US population suffered from herpes simplex virus (HSV) and herpes zoster virus (HZV) infections, and 83.3 million cases of human papilloma virus (HPV) infection were noted.2 Indeed, at any given time, it has been reported that at least 25% of the population of the US suffer from at least 1 skin disease5,6 — a state that constitutes a significant global burden of disease.2, 710 A recent study from the US on the burden of skin diseases demonstrated that skin disease was 1 of the top 15 groups of medical conditions for which prevalence and health care spending increased the most between 1987 and 2000, with approximately 1 in 3 persons diagnosed with a skin disease at any given time (see Table 14.1).

Table 14.1 Prevalence of selected skin diseases in the US

Skin disease Prevalence in millions as at 2004
Acne (cystic and vulgaris) 50.2
Actinic keratosis 39.5
Atopic dermatitis 15.2
Benign neoplasms/keloid 29.4
Bullous diseases 0.14
Contact dermatitis 72.3
Cutaneous fungal infections 29.4
Cutaneous lymphoma 0.02
Drug eruptions 2.6
Hair and nail disorders 70.5
Herpes simplex and zoster 165.0
Human papillomavirus/warts 58.5
Lupus erythematosus 0.36
Psoriasis 3.1
Rosacea 14.7
Seborrheic dermatitis 5.9
Seborrheic keratosis 83.8
Skin cancer— melanoma 0.72
Skin cancer— non-melanocytic 1.2
Skin ulcers and wounds 4.8
Solar-radiation damage 123.1
Vitiligo 1.5

(Source: adapted and modified from Bickers et al. 2006)11

Exposure of the skin to UV light has the potential to induce the formation of high concentrations of reactive oxygen species (ROS) which can destabilise ROS signalling functions and damage organelles and modify the structures of important molecules such as proteins, lipids and genetic material.12 Sunlight, particularly ultraviolet B (UVB) (wavelength 290–320 nm), is responsible for sunburn, but also causes cellular damage. UVA light (wavelength 320–400 nm) burns less than UVB (wavelength 290–320 nm) and penetrates deep into the dermis (as far as the boundary with the epidermis). UVA light makes up the majority of sunlight, and is absorbed by a wide range of molecules, which can become photosensitisers, and can do more damage to the skin due to its greater ability to penetrate. Environmental pollutants such as ozone and oxides of nitrogen and sulphur are also able to produce free radicals in the skin, thereby also risking skin damage.13 Although formed in the outer layers of the epidermis, these radicals induce damage in deeper layers in a manner similar to UV light.

A number of nutraceuticals have been claimed to exhibit useful activities in the area of skin health, including proanthocyanidins and the pine bark extract Pycnogenol, carotenoids, polyunsaturated fatty acids (PUFAs), tea, soy, glucosamine and melatonin.14

Lifestyle factors

Smoking

The adverse health risks associated with smoking are well documented and this is also important for overall skin health. Smoking has been associated with the positive and negative prevalence of numerous diseases and conditions of the skin (see Table 14.2).15, 16

Epidemiological studies have demonstrated that tobacco smoking is one of many factors that significantly contributes to premature skin ageing in addition to other factors such as age, sex, skin pigmentation, sun exposure history, and alcohol consumption.1720 Moreover, smoking is the causal factor of smoker’s wrinkles. Similarly, as with chronic exposure of the skin to ultraviolet radiation, tobacco also promotes manifested alterations in the structure and composition of the epidermis and dermis, similarly to that observed with photo-ageing. 21, 22, 23 In a recent study, tobacco smoking, but not ultraviolet exposure, was determined to be a strong predictor of skin ageing.24

Although smoking may have certain beneficial effects on some skin diseases (as described in Table 14.2), it is exceptionally difficult to favour this habit which is highly damaging to overall health. Tobacco smoking is currently the leading preventable cause of disease and death in Western countries, and some of its beneficial effects on the skin are significantly dwarfed when compared to the hazard risks to health encountered with habitual tobacco use for both smokers and those who are exposed to secondary tobacco smoke, therefore it cannot be recommended.

Life stressors

Psycho-emotional stressors have long been expected to exacerbate or even trigger allergic diseases such as atopic dermatitis (see Figure 14.1).26, 27

Psychodermatological or psychocutaneous disorders are conditions resulting from the interaction between the mind and the skin. There are 3 major groups of psychodermatological disorders recognised; psychophysiologic disorders, psychiatric disorders with dermatologic symptoms, and dermatologic disorders with psychiatric symptoms.28

A number of human studies have reported associations between personality traits and psychic disturbances such as stress perception, anxiety, or depression and atopic dermatitis severity or even onset.2932

Depression in dermatology patients often is multi-factorial in its cause. Genetic factors, psychosocial stressors, age of patients at onset of skin disease, body areas involved, physical discomfort (i.e. pruritus, pain, or burning), and clinical severity all are potential contributors.

The nature of the mechanisms that link stress and exacerbation of skin inflammation remain largely unknown. Recent studies suggest psycho–neuro–immunologic factors and emotional stressors are important in its evolution (Figure 14.1).33

The established explanation is that immune balance is altered by activation of 2 stress axes; namely, activation of the hypothalamic–pituitary–adrenal (HPA) axis that raises cortisol levels, and activation of the sympathetic nervous systems which raises adrenaline levels (Figure 14.1).34 This mechanism of activity has been further investigated in wound-healing experiments. For more than a decade it has been extant that stress/stressors (which can range in magnitude and duration) can significantly slow wound healing.35, 36

Itch is a major feature of many skin diseases, which adversely affects patient’s quality of life. Recently it was shown that cognitive factors, such as helplessness and worrying, and the behavioural response of scratching were indicated as possible worsening factors. This is consistent with overall findings that implicate a biopsychosocial model for the itch sensation.37

Sunlight/ultraviolet (UV) exposure

Sunlight exposure produces a variety of adverse cutaneous effects, such as erythema, photosensitivity, and immunologic alterations, that represent acute events.

Among harmful environmental factors that contribute to extrinsic ageing, are the long-term effects of repeated exposure to UV that leads to carcinogenesis and photo-ageing as long-term consequences.

Acute adverse effects of sun exposure

Acute overexposure to sunlight causes sunburn, primarily because of ultraviolet B (UVB) (290–320 nm) radiation. This is characterised by erythema, oedema, and tenderness. Sunburn represents injury to both epidermal and dermal layers.38

Skin cancers

The influence of painful sunburns and lifetime sun exposure to the skin has also been studied in other skin diseases.40 Lifetime sun exposure was predominantly associated with an increased risk of squamous cell carcinoma (SCC) and actinic keratoses and to a lesser degree with basal cell carcinoma (BCC). By contrast, lifetime sun exposure appeared to be associated with a lower risk of malignant melanoma, despite the fact that lifetime sun exposure did not diminish the number of melanocytic nevi or atypical nevi. Neither painful sunburns nor lifetime sun exposure were associated with an increased risk of seborrheic warts.

Chronic adverse effects of sun exposure

Contact allergy and the skin

Contact allergy caused by ingredients in cosmetic products is a well-known problem (see Table 14.3). In the US it has been reported that approximately 6% of the general population has a cosmetic-related contact allergy, mainly caused by constituent compounds such as preservatives or fragrances in the cosmetic product.4649

Table 14.3 Important allergens for consideration in cosmetics

Allergen Function
Amerchol™ L101 Emulsifier
p-Aminobenzoic acid Sunscreens
Balsam of Peru (Myroxylon pereirae) Fragrance
Benzophenone 3 Sunscreens
2–Bromo–2–nitropropane–1,3–diol (Bronopol) Preservative
Butylated hydroxyanisole Antioxidant
Butylated hydroxytoluene Antioxidant
Cetyl/stearyl alcohol Emulsifier
Cocamidopropyl betaine Surfactant
DMDM hydantoin

Fragrance mix Fragrance Formaldehyde Preservative Glyceryl thioglycolate Hair permanent wave (perming) compound Hydroxy–isohexyl–3–cyclohexane carboxaldehyde (HMPPC Lyral®) Fragrance Imidazolidinyl urea Preservative Iodopropynyl butylcarbamate Preservative Kathon CG Preservative Lanolin alcohol (wool alcohol)

Methyl methacrylate Nail Industry Methylisothiazolinone/methylchloroisothiazolinone Preservative Methyldibromo glutaronitrile Preservative p-Phenylenediamine Hair dye Oxybenzone Sunscreens Parabens Preservative Quaternium–15 Preservative Toluene sulphonamide (formaldehyde resin) Nail polish cosmetic Tosylamide/formaldehyde resin Nail cosmetic Tea tree oil Essential oil Thimerosal Preservative

(Source: data adapted and modified from Ortis, Yiannias49 and Orton, Wilkinson)50

Mind–body medicine

The endocrine system serves as a central gateway for psychologic influences on health. Stress and depression can cause the release of pituitary and adrenal hormones that have multiple effects on immune function that can subsequently influence skin physiology. Furthermore, skin problems associated with depression and or anxiety can be classified accurately as psychophysiologic disorders. They can be elicited and worsened by psychologic factors and, in turn, living with them can be associated with a higher prevalence of emotional disorders, such as depression and anxiety.51 Hence, there is a brain–skin connection via psychoneuroimmunological–endocrine mechanisms that, through human behaviours, can strongly influence the initiation and exacerbation of skin disorders.

The mechanism by which hypnosis produces improvement in symptoms and in skin lesions is not completely understood. Hypnosis may help regulate blood flow and other autonomic functions not usually under conscious control. The relaxation response that accompanies hypnosis may alter neurohormonal systems that in turn regulate many body functions.53

Hypnosis may be used to help control harmful habits, such as scratching. It also can be used to provide immediate and long-term analgesia, reduce symptoms such as pruritus, improve recovery from surgery, and facilitate the mind–body connection to promote healing of the skin.

Nutrition and the skin

Nutritional dermatology is the use of elimination diets, nutritional regimens and supplements to augment treatment and prevention of dermatologic disorders.

Treatment regimens have their origins from numerous areas that are diversely derived from complementary medicine techniques, historical use and traditional healing systems such as Ayurveda, and the systems fashioned by various empirical nutritional therapists.66

As is well known, diet has been recognised to be important in the treatment of several disorders. For example, stimulants and hot foods have been related to acne rosacea,67 wheat gluten to dermatitis herpetiformis,68 and zinc deficiency to acrodermatitis enteropathica.69 Other nutritional deficiencies have historically been recognised to play a role in dermatitis, such as in vitamin B1 deficiency that leads to pellagra.70

Food sensitivities

Population-based assessments of food allergy are scarce.71 Despite the difficulties in obtaining firm population-based data on the prevalence of food allergies, there has been evidence for a general increase in food allergies, documented best for peanut, sesame, and kiwi, that could be attributed to environmental and dietary factors including reduced immune stimulation from infection; that is, the hygiene hypothesis. There have been changes in the components of the diet, including antioxidants, fats, and nutrients such as vitamin D, as well as the use of medications.72, 73, 74

Addressing food allergies (food sensitivities), is an important nutritional elimination procedure. These are reactions to foods that are far broader than the classical reactions such as urticaria, itchy eyes, and rhinitis. They include any inflammatory manifestation as well as a variety of neurological and other non-inflammatory conditions.75

Food hypersensitivity can be the first stage in the development of allergic diseases, such as atopic eczema.76 It has been reported that clinicians have found that elimination of specific foods found by food challenge to elicit symptoms can lead to significant improvement in eczematous symptoms.77 There is a vast amount of scientific literature claiming that dietary elimination causes improvement of atopic eczema in some cases. However, a recent systematic review portrays the evidence available as weak and the issue of exclusion diets in atopic eczema remains contentious.78

Diets

The eradication from the diet of chemicals is an effective way to eliminate potential skin diseases that are aggravated by chemicals. The Palaeolithic diet has addressed such issues in the scientific/medical literature.79 The essential of this diet involves the consumption of those foods that have a low glycemic index (GI) and consists of meat, fish, vegetable, fruit, roots, and nut consumption and excludes grains, legumes, dairy products, salt, refined sugar, and processed oils. Adherence to this diet in turn minimises the consumption of pesticides, petroleum-based fertilisers, preservatives, artificial flavourings, and artificial food colours.

Acne vulgaris

Studies have reported that excessive intake of refined carbohydrates might contribute to the high rates of acne seen in Western countries through a mechanism involving insulin-stimulated androgen production and that hence nutrition-related lifestyle factors play a role in the pathogenesis of acne and that adhering to a diet with low GI foods improves skin health.80, 81, 82 A recent Cochrane review has reported that improving lifestyle eating profiles such as adhering to a low-GI dietary regimen can improve health outcomes,83 which could in turn improve skin health. The systematic review reported that overweight or obese people on a low-GI diet lost more weight and had more improvement in lipid profiles than those receiving carbohydrate diets. Body mass, total fat mass, body mass index (BMI), total cholesterol and LDL cholesterol all decreased significantly more in the low GI group. In studies that compared ad libitum low-GI diets to conventional restricted energy low-fat diets, participants fared as well or better on the low-GI diet, even though they could eat as much as desired. Therefore, this review concluded that lowering the glycaemic load of the diet appears to be an effective method of promoting weight loss and improving lipid profiles and can be simply incorporated into a person’s everyday lifestyle. This improvement may well extend to include better skin health. A recent study further emphasises that there could be a possible role of desaturase enzymes in sebaceous lipogenesis and the clinical manifestation of acne.84

Nutritional supplements

Different data support the notion that dietary bioactive molecules such as vitamins, carotenoids, polyphenols and trace elements such as zinc and selenium contribute to the maintenance and improvement of skin integrity and physiology, as well as preventing deleterious effects induced by ageing and environmental stressors.

Beneficial effects have been demonstrated in various experimental model systems including topical application of these ingredients. Recently, oral supplements containing various dietary bioactive molecules have also been reported to be beneficial for skin.87

Vitamins

High doses of vitamin A should be avoided (for used cautiously with contraception) in women who may wish to conceive due to potential teratogenicity effects on the fetus.

There have been approximately 2500 new retinoid compounds synthesized.90 Vitamin A stimulates various aspects of wound repair. It affects fibroplasia, collagen synthesis, epithelialisation, and angiogenesis and is involved in inflammatory processes with specific effects on macrophages, which play a dominant role in wound healing.91

Retinoids already approved for the treatment of dermatological conditions include:

The treatment of disorders of abnormal keratinisation, such as Darier’s disease and Kyrle’s disease, has been ascribed to etretinate and acitretin which are established in Europe for the treatment of Darier’s disease and ichthyosis, especially the nonbullous congenital type.92 In the US, however, these compounds have only been approved by the FDA for psoriasis. Palmoplantar keratoderma also responds well to these drugs, but treatment is justified only in severe cases.93 Pityriasis rubra pilaris has been treated successfully with isotretinoin in the past,94 but now acitretin seems to be the drug of choice in Europe.

It has been reported that retinoids possess certain properties that make them good candidates for cancer prevention and therapy. They are metabolically active compounds that can induce changes in cellular function and appearance, and that can modify the expression of a variety of genes involved in cell growth and differentiation.95

Topical tretinoin, at concentrations of 0.05% and 0.1%, have been used in combination with hydroquinone and corticosteroids for the treatment of melasma.96 Isotretinoin, etretinate, and acitretin have all been used in recalcitrant cases of lichen planus and cutaneous lupus erythematosus with good results.97 Erythropoietic protoporphyria responds to treatment with beta-carotene.

The use of retinoids has been significantly more successful in skin cancer prevention in high-risk patients. Treatment of patients suffering from xeroderma pigmentosum with 2mg/kg/day isotretinoin for 2 years resulted in an average reduction of 63% in the number of skin cancers compared with the 2-year interval before intervention.98

Furthermore, patients with nevoid basal cell carcinoma (BCC) syndrome have been reported to benefit from the same dose of isotretinoin treatment, as there was a rapid decrease in the number of new BCCs.99 Also transplant recipients are also a high-risk group for the development of skin cancer. It has been reported that etretinate at a dose of 50mg/day and acitretin at 30mg/day reduced the incidence of skin cancer in renal transplant recipients.100 An additional group that is appropriate for skin cancer chemo-prevention includes patients with premalignant lesions and a history of 1 or a few skin cancers. Vitamin A (25 000IU per day) appears to benefit patients with many actinic keratoses and a history of fewer than 3 skin cancers101 but not those with 4 or more cancers.102 Albeit retinoids have shown promise as skin cancer chemo-prevention agents, their benefits do not persist after discontinuation of treatments. It should be also noted that long-term use is associated with possible severe side-effects and therefore careful patient monitoring is required.

Researchers have reported favourable responses to isotretinoin and etretinate in patients with multiple keratoacanthomas.103, 104 Other studies with patients with SCC were also reported to be successfully treated with oral isotretinoin.105 However, in most cases responses of advanced skin cancers to retinoids have been largely disappointing.

Vitamin E

Vitamin E includes tocopherols and tocotrienols and is a putative antioxidant with no known catalytic roles. However, given that it is a fat soluble (lipophilic) vitamin, it may have important intracellular metabolism modifying functions.118

In contrast, a study by Werninghaus and colleagues122 has reported that daily supplementation of healthy individuals with 400IU of natural-source vitamin E for up to 6 months did not significantly alter UV-induced skin damage, as assessed by minimal erythema dose and sunburn cell formation.

A recent review123 has cited numerous topical studies (laboratory animal and human studies) that have demonstrated that vitamin E application prior to UV exposure significantly reduced:

Early uncontrolled trials, using topical application of vitamin E have demonstrated relief of pain and aided in the healing of oral herpetic lesions (gingivostomatitis or herpetic cold sores). In 2 studies, the affected area was dried and cotton saturated with vitamin E oil (20 000–28 000IU per ounce) was spread over the lesions for 15 minutes.124, 125 Pain relief was noted within 15 minutes to 8 hours, and the lesions regressed more rapidly than normal. In some cases, a single application was beneficial, but large or multiple lesions responded better when treated 3 times daily for 3 days. In a further study of 50 patients with herpetic cold sores, the content of a vitamin E capsule was applied to the lesions every 4 hours. The results of this study126 demonstrated prompt and sustained relief of pain and the lesions healed more rapidly than was otherwise expected.

When assessing studies on the use of vitamin E, the natural versus the synthetic form of the vitamin needs to be taken into consideration. There are numerous studies that have reported on negative effects and these studies have utilised the synthetic form of the vitamin.

Vitamin D

The essential biochemistry of vitamin D3 begins with it being one of the major regulators of calcium homeostasis. It is absorbed from the gut but is also synthesized in the skin following exposure to UV light. It is activated by hydroxylation first in the liver to form 25-hydroxyvitamin D3 (25OHD3) and then in the kidneys to form a variety of metabolites, the most potent of which is 1,25(OH)2D3.

Psoriasis

Chronic plaque psoriasis is the most common type of psoriasis and is characterised by redness, thickness and scaling. A recent systematic review that investigated the efficacy of cortecosteroid medication and vitamin D on chronic plaque psoriasis has concluded that dithranol and tazarotene performed better than placebo and that comparisons of vitamin D against potent or very potent corticosteroids found no significant differences. However, combined treatment with vitamin D/corticosteroid performed significantly better than either vitamin D alone or corticosteroid alone.127

Calcipotriol, a vitamin D analogue (and a synthetic derivative of calcitriol), has been reported in a randomised controlled trial (RCT) of supervised treatment of psoriasis in a day-care setting can be considered as a first-line approach in clinical practice.128 Patients who participated in this multi-centre clinical trial were treated at the day-care centre, using the care instruction principle of daily visits during the first week and twice-weekly visits subsequently for up to 12 weeks. The study concluded that topical treatment in combination with interventions explicitly focusing on improvement of coping behaviour and psychosocial functioning may further increase the degree of improvement in the psychosocial domains of quality of life in this patient group.

Recently a clinical trial reported that calcitriol ointment at a concentration of 3μ/g was a safe, effective, and well-tolerated option for the long-term treatment of chronic plaque psoriasis. Clinical improvement was maintained for up to 52 weeks, with no clinical effect on calcium homeostasis or other relevant laboratory test parameters observed.129

Atopic dermatitis

In a recent double-blinded randomly assigned pilot study participants took ergocalciferol 1000IU or an identical-looking placebo once daily for 1 month for winter-related atopic dermatitis in children.130 Four out of the 5 child participants who received vitamin D compared with 1 out of the 5 who received placebo had a documented improvement but the difference was not statistically significant when the differences between baselines for the 2 groups were calculated. A study with larger participant numbers is required. The role of vitamin D in inflammatory skin diseases such as atopic dermatitis in children remains to be elucidated. Recently the American Academy of Paediatrics in the US recommended an increase to the daily dose of vitamin D in children from 200 to 400IU per day.131 Noticeable effects, on the incidence of atopic dermatitis hence remain to be reported.

Skin cancers and malignant melanomas

New scientific findings convincingly demonstrate that Vitamin D deficiency is associated with a variety of severe diseases including various types of cancer.132 Hence sun exposure has been reported from various locations 133136 to be associated with a relatively favourable prognosis and increased survival rate in various malignancies, including malignant melanoma. A recent meta-analysis concluded that there is a growing body of evidence that Vitamin D may be of significant importance for the pathogenesis of cutaneous malignant melanoma.137

B Group Vitamins

The vitamin B complex consists mainly of thiamine (vitamin B1), riboflavin (vitamin B2), niacin (vitamin B3), pyridoxine (vitamin B6), cyanocobalamin (vitamin B12) and folate (vitamin B9). Also vitamins of the B complex are not widely used for the treatment of dermatological disorders.

Sporadic studies have been reported in the scientific literature which investigated the topical application of specific B group vitamins to the skin. Topical nicotinamide, the physiologically active form of niacin, was reported to have efficacy comparable to that of topical clindamycin in the treatment of acne vulgaris138 and has produced good results in patients with necrobiosis lipoidica.139 In combination with tetracycline, nicotinamide was successful in 1 patient with dermatitis herpetiformis.140 The combination of nicotinamide and tetracycline has also been proposed as an alternative to systemic steroids in the treatment of bullous pemphigoid.141 The success of nicotinamide in the treatment of these skin disorders perhaps is attributable to a re-regulation of the inflammatory state of the skin.

Other B-complex vitamins that have been used in the treatment of skin disorders include pyridoxine, for the management of erythropoietic protoporphyria,142 and vitamin B12, in combination with folic acid, for the treatment of vitiligo.143

Minerals

Zinc

Zinc is an essential component of many metallo-enzymes involved in cell activities such as protein synthesis DNA and RNA replication, and cell division and it is crucial for the normal development of the skin.144

Acne volgaris

Studies detecting low serum zinc levels in patients with acne have a long history.145,146 The finding that zinc was bacteriostatic against Propionibacterium acnes, inhibited chemotaxis, and could decrease tumour necrosis factor-alpha production provided evidence of its usefulness. Subsequently numerous studies have demonstrated that oral zinc was effective in the treatment of severe and inflammatory acne,147153 more so than it was for mild or moderate acne.154, 155

Despite the hopeful results, oral doses used in these studies (i.e. 200mg of zinc gluconate/day, 400 or 600mg of zinc sulfate/day) were associated with nausea, vomiting, and diarrhoea.

Gastrointestinal side-effects can be ameliorated somewhat by ingesting zinc directly after meals. One to 2 milligrams of copper supplementation may be recommended with long-term zinc therapy to prevent copper deficiency as zinc decreases the absorption of copper. Oral zinc salt supplementation has been shown to be equally or less effective than oral tetracyclines.156159

One study, however, showed that oral zinc sulfate had no effect on male patients with moderate acne after 8 weeks of therapy, despite evidence of systemic absorption.160 Limited efficacy and poor patient compliance caused by gastrointestinal side-effects have limited the use of oral zinc for the treatment of acne. Further trials need to be conducted to assess the efficacy and side-effects of lower doses of orally administered zinc.

Selenium

Selenium has a catalytic role, as a component of glutathione peroxidase, in the regulation of oxygen metabolism, particularly in catalysing the breakdown of H2O2. Studies with laboratory animals have implicated selenium deficits in skin cancer tumorigenesis.162 Human studies however have proven controversial.

Other nutritional supplements

Alpha-hydroxy acids (AHAs)

AHAs are weak organic acids that can be found in fruits, milk sugars, and plants. Glycolic acid (from sugar cane) and lactic acid (from milk) are 2 types of AHAs found in over the counter acne products, but these AHAs are often chemically synthesized rather than isolated from natural sources. Moreover, fruit acids are a special group of organic acids found in many natural foods and consist of citric, gluconic, gluconolactone, glycolic, malic and tartaric acids.

Acne vulgaris

Studies have demonstrated that AHAs are safe and efficacious, in combination, such as in glycolic acid/retinaldehyde preparations,170, 171, 172 as well as its ability to accompany common topical anti-acne therapies. Also, this combination has been reported to prevent and repair post-inflammatory hyper-pigmented skin that was associated with acne.173 Retinaldehyde, a precursor of retinoic acid, has shown de-pigmenting activity whereas glycolic acid decreases excessive pigmentation by a wounding and re-epithelization process. There appears to be a synergistic effect when these 2 compounds are used in combination.

An early double-blind clinical trial on 150 patients to evaluate the efficacy and skin tolerance of the alpha hydroxy acid gluconolactone 14% in solution (Nuvoderm lotion) in the treatment of mild to moderate acne was compared to its vehicle (placebo) and 5% benzoyl peroxide lotion. The results of the study demonstrated that both gluconolactone and benzoyl peroxide had a significant effect in improving patients’ acne by reducing the number of lesions (i.e. inflamed and non-inflamed). Furthermore, fewer side-effects were reported by patients treated with gluconolactone when compared with benzoyl peroxide.174 Irritation was the main adverse effect when gluconolactone was in high concentrations.

Functional foods

Probiotics

A recent review has documented the numerous experimental studies that have found that probiotics exert specific effects in the intestinal lumen and on epithelial cells and immune cells with anti-allergic potential.183 The review also documented that the barrier function and the innate immune system of the skin indicates that the skin’s microbiota have a beneficial role, much like that observed with the gut microflora.184

Atopic dermatitis

Studies worldwide have shown that an environment rich in microbes in early life reduces the subsequent risk of developing allergic diseases such as atopic dermatitis.185 Continuous stimulation of the immune system by environmental saprophytes via the skin, respiratory tract and gut appears to be necessary for activation of the regulatory network including regulatory T-cells and dendritic cells. Substantial evidence now shows that the balance between allergy and tolerance is dependent on regulatory T-cells. Tolerance induced by allergen-specific regulatory T-cells appears to be the normal immunological response to allergens in non-atopic healthy individuals. Healthy subjects have an intact functional allergen-specific regulatory T-cells response, which in allergic subjects is impaired. Evidence on this exists with respect to atopic dermatitis, contact dermatitis, allergic rhinitis and asthma.

In a large meta-analysis of the current literature regarding the use of prenatal and postnatal probiotics for the prevention and treatment or either of atopic dermatitis, Lee and colleagues have reviewed and analysed the data from 10 studies.186 Six of the 10 studies showed evidence to support the use of probiotics both prenatally and postnatally for the prevention of atopic dermatitis. A risk reduction as high as 61% was seen that was attributed mainly to the prenatal use of probiotics. For the treatment of atopic dermatitis there was no significant difference detected between those that used probiotics and those that did not. Patient education may further increase the likelihood of successful preventative measures.187

Eczema

Probiotic bacteria have been proposed as an effective treatment for eczema, and recently a number of clinical trials have been undertaken and recent systematic reviews have analysed the published data. Two reviews by the same research group have found that there was significant heterogeneity between the results of individual studies, which could be explained by the use of different probiotic strains.188,189 A subgroup analysis by age of participant, severity of eczema, presence of atopy or presence of food allergy did not identify a population with different treatment outcomes to the population as a whole. The adverse events reported identified some case reports of infections and bowel ischaemia caused by probiotics. The overall conclusions from the reviewed was that probiotics were not an effective treatment for eczema, and probiotic treatment carried a small risk of adverse events.

A significant caveat is that there was a strong heterogeneity in probiotic formulations used and this may well be the most important explanation as to probiotic efficacy failure thereby significantly weakening the conclusions of the systematic reviews.

Herbal medicines

Herbal medicines that are used as medicines comprise plants/plant part(s) that contain specific active ingredients that enable it to be used for healing purposes or symptom relief. There are a number of herbs that have been reported to have traditional uses for skin problems and these include examples such as chamomile, fennel, lavender, lemon balm, pot marigold, red clover, rose, sage and thyme.195 The following discussion follows the use of herbal medicines by treatment type.

Herbal medicines for acne

The topical application and oral ingestion of herbal medicines and plants that have been indicated for acne problems and with anti infective properties such as that produced by P acnes are presented in Tables 14.5 and 14.6.196, 197

Table 14.5 Topically applied herbal medicines and plants/plant parts for the treatment of acne, condyloma and verruca vulgaris

Aloe vera/Aloe Barbadensis Ironweed/Veronia antihelminitica
American may apple/Podophyllum peltatumΦ Kramiria triandra Ruis plus escin–beta–sitosterol plus lauric acid
Bittersweet nightshade/Solanum dulcamaraΦ Lilac/Azadirachta indica
Black walnut/Juglans regia Oak bark/Quercus robur
Borage/Borago officinalis Oat straw/Avena sativaΦ
Compositae/Artemesia vulgaris and A. Absinthum Onion/Allium cepa
Calotropis/ Calotropis proceraΦ (used in India to treat warts) Oregon grape root/Mahonia aquifolia/ berberine
Crinum/Crinum macowanii Pea/Pisum sativum
Cucumber Pomegranate/Punica granitum
Duckweed/Lemma minor Pumpkin/Cucurbita pepo
English walnut/Juglans regia Rue/Ruta graveolens
Fresh lemon East Indian globe thistle/Sphaeranthus indicus L
Fruit acids (citric/gluconic/gluconolactone/glycolic/malic/tartric) White Marudah/Ternialia arjuna
Garlic/Allium sativum Tea Tree Oil/Melaleuca alternifolia
Grapefruit seeds Turmeric/Curcuma longa
Greater celandine/Chelidonium majusΦ (used in China to treat warts) Vinegar
Indian Madder/Rubia cordifolia Vitex/Vitex agnus–castus L
Indian Sarsaparilla/Hemidesmus indicus Witch-hazel/Hamamelis virginiana sp

Note: These herbal medicines and plants/plant parts are effective in inhibiting the pathogenesis of P acnes in vitro, in vivo and for condylomaΦ and verruca vulgarisΦ

Table 14.6 Orally administered herbal medicines and plants/plant parts and otherΔ for the treatment of acne

Burdock root/Arctium lappa
ΔBrewer’s yeast/Saccharomyces cerevisiae
Ku shen/Sophora flavescens
Indian ginseng/Withania somnifera
Mukul myrrh tree/ Commiphora mukul

(Source: modified from Magin et al. 2006)196

It has been reported that tannins (substances present in the seeds and stems of grapes, the bark of some trees, and tea leaves) have been employed topically to treat acne because of their natural astringent properties.198 A herb that is known for its astringent and anti-viral properties is witch-hazel (Hamamelis virginiana). This herb is from a genus of flowering plants in the family Hamamelidaceae, with 2 species in North America (H virginiana and H vernalis), and 1 each in Japan (H. japonica) and China (H mollis).199, 200 There are no studies that have reported the efficacy of witch-hazel in the treatment of acne.

Tea tree oil (Melaleuca alternifolia)

Tea tree oil was studied in an early Australian study201 by comparing the efficacy of 5% tea tree oil to that of 5% benzoyl peroxide. A single-blinded, RCT on 124 patients was performed to evaluate the efficacy and skin tolerance of 5% tea tree oil gel in the treatment of mild to moderate acne. The study concluded that both preparations, namely 5% tea tree oil and 5% benzoyl peroxide, had a significant effect in ameliorating the patients’ acne by reducing the number of inflamed and non-inflamed lesions (i.e. open and closed comedones), although the onset of action in the case of tea tree oil was slower. Also fewer side-effects were reported by patients treated with tea tree oil. A further study supported the use of tea tree oil in the treatment of acne, and demonstrated that the terpinene-4-ol was not the sole active constituent of the oil that may have antimicrobial activity.202 A subsequent systematic review, although not finding conclusive evidence that tea tree oil was useful in the treatment of acne, did specify that the emerging evidence was promising.203, 204

Tea tree oil has been recently studied in a double-blind RCT of 60 patients with mild to moderate acne vulgaris.205 Participants were randomly divided into 2 groups and were treated with tea tree oil gel (n = 30) or placebo (n = 30) and were followed every 15 days for a period of 45 days. The study concluded that topically applied 5% tea tree oil is an effective treatment for mild to moderate acne vulgaris.

Tea tree oil may also have additional effects on the skin as reported recently with the first study to show experimentally that tea tree oil reduced histamine-induced skin inflammation.206

Vitex (Vitex agnus castus L)

The traditional use of this herb has been reported to be for the efficacious treatment of premenstrual acne.207, 208 The whole fruit extract is thought to act to rebalance follicle stimulating hormone and luteinising hormone levels in the pituitary gland therby increasing progesterone and simultaneously decreasing oestrogen levels.207 The German Commission E Monographs (hereafter referred to as the German Commission) have recommended an oral dose of 40mg/day.209 The main adverse effects reported were gastrointestinal upset and rash. From the published scientific data, Vitex has been recently reported to be a safe medicinal herb.208 There is though a requisite for more controlled studies to demonstrate the efficacy of this herb.

For an extensive review that has recently documented the extensive literature on herbal medicines for the treatment of acne refer further to the review by Magin and colleagues.196

Herbal medicines for wounds, burns and radiation dermatitis

Aloe vera

Several case reports have documented that Aloe vera reduced itching, burning and scarring associated with radiation dermatitis.210 An early study demonstrated that Aloe vera was effective in skin wound caused by burns.211 This study showed the effectiveness of Aloe vera gel on a partial thickness burn wound, concluding that additional studies were warranted. Also, that only some minor adverse effects, such as discomfort and pain were encountered in the 27 cases.

A recent systematic review while accepting that Aloe vera has been traditionally used for burn healing the clinical evidence for its efficacy remains unclear.212 The study concluded that due to the differences of products and outcome measures employed by different study designs, there was paucity of information and hence to draw specific conclusions regarding the effect of Aloe vera for burn wound healing was difficult. However, the authors did also comment that given the cumulative scientific evidence that exists, this would tend to support that Aloe vera might be an effective intervention used in burn wound healing for first to second degree burns. Moreover it was also concluded that well-designed trials with sufficient details of the contents of the Aloe vera products used (percent content of the gel and liquid extracts) should be carried out to determine the efficacy of the herb.

Honey

For centuries the use of honey has provided a therapeutic ointment option for wounds.213 There is a growing body of scientific literature promoting the use of sterilised honey-based products in wound care, demonstrating their efficacy, cost-effectiveness and exceptional record of safety.214, 215

A recent Cochrane review concluded that honey may improve healing times in mild to moderate superficial and partial thickness burns compared with some conventional dressings.216

Herbal medicines for skin wounds due to herpes simplex

Lemon balm (Melissa Oficinalis L)

Extracts of the leaves of lemon balm (Melissa officinalis) have been investigated as a topical treatment for herpes simplex. Randomised trials have demonstrated that Lemon balm was effective for herpes simplex. In 1 study with 116 patients with an acute herpes simplex outbreak applied a lemon balm preparation or a placebo cream. Treatment was begun within 72 hours of the onset of symptoms and administered 2–4 times daily for 5–10 days. Healing was assessed as very good by 41% of patients in the lemon balm group and by 19% in the placebo group.221 A further study which was a DBRCT was carried out with the same balm preparation with the aim of proving efficacy of the standardised balm mint cream (active ingredient: 1% Lo–701 dried extract from Melissa officinalis L leaves [70:1]).222 The lemon balm cream or placebo cream was applied to the affected area 4 times daily for 5 days. On the second day of therapy, the symptom score was significantly lower in the active-treatment group than in the placebo group, with a non significant trend in favour of the lemon balm treatment at the end of the study.

Liquorice (Glycyrrhiza glabra and Glycyrrhiza uralensis)

The topical application of Glycyrrhiza sp has been associated with historical sources from ancient manuscripts from China, India and Greece.223 Laboratory studies have demonstrated inhibition of the varicella zoster virus. Human clinical trials have yet to be conducted, although the topical application of liquorice is reported to be safe.207

Herbal medicines for bacterial and fungal infections

As previously outlined a number of herbal medicines can inhibit the growth of P acnes in vitro (Table 14.5).197 Similarly tea tree oil has demonstrated significant antibacterial activity in vitro against a variety of micro-organisms that include, Propionibaterium acnes, Staphylococcus aureus, Escherichia coli, Candida albicans, Tricophyton mentagrophytes and Trichophyton rubrum.198

Tea tree oil has also been used as a topical antiseptic agent since the early part of the 20th century for a wide variety of skin infections, including bacterial and fungal.224 In a study with a fungal infection tea tree oil cream (10% w/w) appeared to reduce the symptomatology of tinea pedis as effectively as tolnaftate 1% but was no more effective than placebo in achieving a mycological cure.225 In a further study which assessed the efficacy and tolerability of topical application of 1% clotrimazole solution compared with that of 100% tea tree oil for the treatment of toenail onychomycosis, the study concluded that the topical therapy, provided improvement in nail appearance and symptomatology by both treatments.226 However it was concluded by another study that it should not be employed in burn wounds to the skin because of tea tree oil’s cytolytic effect on epithelial cells and fibrolasts.227

Garlic (Allium sativum)

Reports document that ajoene, an organic trisulphur originally isolated from garlic, has an antimycotic activity which has been widely demonstrated both in vitro and in vivo.228 A study of short duration demonstrated that the use of ajoene as a 0.4% (w/w) cream resulted in complete clinical and mycological cure in 27 of 34 patients (79%) after 7 days of treatment. The remaining 7 patients (21%) achieved complete cure after 7 additional days of treatment.229 At a 3-month follow up all participants remained free of fungus.

Herbal medicines for scabies

Herbal preparations from essential oils such as anise (Pimpinella anisum) seeds that has displayed antibacterial and insecticidal activity in vitro has been employed topically to treat scabies.198 Neem (Azadirachta indica) is an Indian plant that has been used medicinally in that country.198 In a report of more than 800 villagers in India the paste of neem and turmeric was used topically to treat chronic ulcers and scabies.198 Rigorous data is lacking and further studies are warranted.

Herbal medicines for psoriasis and dermatitis

TCM herbs

Traditional Chinese medicine (TCM) for the treatment of psoriasis and atopic dermatitis has gained significant attention in the last decade.198 TCM deals with the whole-body medicine system whereby the role of the therapy is to regain metabolic balance for the individual. This requires a mixture of herbs.230

Two recent cross-over RCTs investigated the use of TCM in the treatment of atopic dermatitis in which conventional medicine had failed to respond adequately to currently available therapies.231, 232

A Chinese practitioner aided the investigators to formulate a mixture of herbal medicines for the RCTs. The Chinese herbal medicines included Potentilla chinensis, Tribulus terrestris, Rehmannia glutinosa, Lophatherum gracile, Clematis armandi, Ledebouriella sacleoides, Dictamnus dasycarpus, Paeonia lactiflora, Schisonepeta tenuifolia and G glabra. This mixture of herbs was placed in sachets and boiled and then provided to participants as a tea to be consumed daily.231 The 2 (8-week) studies investigated children (atopic eczema) and adults (atopic dermatitis) and the mixed herbal tea was significantly more effective than the placebo tea preparation. The efficacy was associated with significant decreases in erythema and surface damage to the skin. The only serious adverse event reported was elevation of aspartate aminotransferase levels in 2 children which decreased to normal on treatment discontinuation.

Psoriasis is a common, chronic, recurrent inflammatory skin disorder whose aetiology is still unknown. Traditional Chinese herbal medicines have demonstrated efficacy in treating psoriasis, with TCM characterised by a variety of methods of treatment, flexible use of drugs, high efficacy, low recurrence, and few side-effects.233, 234 A recent study with 80 patients randomly assigned to 2 groups, 39 in Group A and 41 in Group B, investigating blood-heat syndrome type psoriasis has demonstrated that the effect of Chinese herbal medicines combined with acitretin capsule was superior to Chinese herbal medicines alone in treating this skin problem.235 This result, though, requires replication by conducting larger trials.

Capsaicin (Capsicum frutescens)

Capsaicin is the active component of cayenne peppers (chilli peppers). Two early trials have demonstrated that 0.025% capsaicin cream was effective in treating psoriasis.239, 240 One study showed significant reductions in scaling and erythema during a 6-week treatment of 44 participants presenting with moderate to severe psoriasis.237 The second study was a double-blind study in patients with pruritic psoriasis randomised to receive either the capsaicin cream or vehicle 4 times a day for 6 weeks.220 Topically applied capsaicin effectively treated pruritic psoriasis.

A review that followed these studies concluded that capsaicin was effective for psoriasis.241

Reported side-effects include a short-lived burning sensation. The German Commission suggest that capsaicin not be used for more than 2 consecutive days with a 2 week lapse between consecutive treatments.198

St Johns wort (Hypericum perforatum L)

A recent double-blind RCT study with a cream containing Hypericum extract standardised to 1.5% hyperforin (verum) in comparison to the corresponding vehicle (placebo) for the treatment of subacute atopic dermatitis.242 The study concluded that the Hypericum cream showed a significant superiority compared to the vehicle in the topical treatment of mild to moderate atopic dermatitis. However, the therapeutic efficacy has to be evaluated in further studies with larger patient cohorts, in comparison to therapeutic standards such as glucocorticoids.

Other herbal medicines

A number of herbs have been approved by the German Commission for the use in atopic dermatitis and psoriasis. These include: Arnica montana, German chamomile (Matricaria recutita), bittersweet nightshade (S. dulcamara), as we all as Breyer’s yeast (S. cereviceae) which are thought to possess anti-inflammatory activity and anti-bacterial effects. Heartseases (Viola tricolor), English plantain (Plantago lanceolata), fenugreek (Trigonella foenum-gaecum), and flax (Linum usitatissium) contain mucilages which can act as emollients that can soothe the skin.198 Furthermore, agrimony (Agrimonia eupatoria), oak (Quercus robur), walnut (Juglans regia), and St John’s wort (Hypericum perforatum) contain tannins and can act as astringents. Oak straw (A. sativa) was also approved for its soothing and antipruritic qualities.198

Aromatherapy

Aromatherapy is the therapeutic use of volatile, aromatic essential oils which are extracted from plants. Aromatherapy may also be regarded as having a close and overlapping relationship to herbal medicine. Aromatic compounds have been used throughout history for spiritual, medicinal, social, and beauty purposes.243

The aromatic oils depicted in Table 14.7 have been reported to be useful in a variety of dermatological conditions especially acne.242 Further, there are only a few clinical trials that have been published on the topical treatment of atopic dermatitis with herbal ointments and the quality of these trials was largely poor. Whereas a review of clinical trials with Mahonia aquifolium reported that taken together, these clinical studies indicated that Mahonia aquifolium was a safe and effective treatment for patients with mild to moderate psoriasis.244

Table 14.7 Aromatherapy — essential oils useful in dermatology

Australian eucalyptus/Eucalyptus radiata
Basil/Ocimum sactum, O basilicum and O gratissimum
Bay essential oil/Pimenta racemosa
Benzoin/Styrax benzoe
Black cumin/Nigella sativa
Black pepper/Piper nigrum
Benzoin/Styrax benzoe
Bergamot/Citrus bergamia
Cajeput/Melaleuca leucodendron
Chamomile/ Chamaemelum nobile
Dandelion/Taraxacum officinale
Frankincense/Boswellia carterii
Fijian fire plant/Acalypha wilkesiana
German chamomile/Matricaria recutita
Geranium/Pelargonium asperum
Heartsease/Viola tricolor
Holly-leaved barberry/Mahonia aquifolium
Jasmine/Jasminum officinalis
Juniper berry/Juniperus communis
Juniper twig/Juniperus communis ram
Knight’s milfoil/Achillea millefolium
Lavender (true)/Lavandula angustifolia and L. spicula
Lavender (French)/Lavandula latifolia
Lemon grass/Cymbopogon citratus
Lemon/Citrus limon
Nialouli/Melaleuca quinquenervia/Viridifolia
Orange/Citrus aurantium
Orange (sweet)/Citrus senesis
Patchouli/Pogostemon cablin
Petitgrain/Citrus aurantium var amara fol
Peppermint/Mentha x piperita
Moroccan chamomile/Ormensis mixta flos
Ravensara/Ravensara aromatica
Rose water/Rosa damascena
Rosemary (verbenone)/Rosmarinus officinalis
Safflower oil, Linoleic acid
Sandalwood/Santalum album and S. spicatum
Scotch pine/Pinus sylvestrus
Sunflower oil, linoleic acid
Tea tree oil/Malaleuca alternifolia
Thick-leaved pennywort/Centella asiatica
Thyme linalool/Thymus vulgaris L.
Verbenone/Rosemarinus officinalis verbenone
Winter Savory/Satureja montana

A reported RCT of a Toto ointment/soap combination (containing Shea butter/Butyrospermum paradoxicum oils with multiple constituents) reported efficacy after an average of approximately 4 weeks of treatment.245 The RCT was of a poor quality.

A further low-quality, open, non-comparative study was of the efficacy and safety of Acalypha wilkesiana ointment in superficial fungal skin diseases. Thirty-two Nigerian patients with clinical and mycological evidence of superficial mycoses were recruited. The study concluded that Acalypha ointment may be used for the treatment of superficial mycoses.246

A recent study with a combination herbal ointment containing Mahonia aquifolium, Viola tricolor and Centella asiatica was reported for the treatment of mild–moderate atopic dermatitis.247 Patients were treated for 4 weeks with the ointment. The primary endpoint was a summary score for erythema, edema/papulation, oozing/crust, excoriation and lichenification according to a 4-point scale. The study concluded that the ointment was not proven to be superior to a base cream. However, a sub-analysis of the data indicated that the cream could be effective under conditions of cold and dry weather.

Low level quality studies investigating Ocimum gratissimum oil products tested were reported to produce a significantly greater reduction in acne lesion count compared with 10% benzoyl peroxide.248, 249, 250

A recent review has investigated the literature and the evidence that exists on the influence that essential oils have on wound healing and their potential application in clinical practice.251 The review concludes that although there is some evidence for efficacy for such essential oils as further larger studies are required.

Physical therapies

Acupuncture

Acupuncture has been demonstrated to influence neurologic, endocrine, immune, and psychologic systems. In dermatology numerous acupuncture methods are recognised (Table 14.8).262

Table 14.8 Different forms of acupuncture used in dermatology

Type of acupuncture Methodology employed
Corporal acupuncture Involves needling with metal needles on 365 known points, located on the so-called meridians (Chinese Jing Luo)
Auricle acupuncture Richly innervated area consisting of 130 points on the auricle that can evoke various changes in the physiological functions of the body
Electro-acupuncture Consists of electric stimulation using a light electric current with different frequencies. This is applied to the needles influencing the skin and underlying tissues in the region of the acupuncture point
Electro-puncture Effect is rendered directly with electric current by means of electrodes inserted into the acupuncture point. The effect with this method is more superficial compared to electro-acupuncture
Moxibustion Cones are placed on the acupuncture point — wormwood or the wormwood cigar is held at a distance (pecking method), which results in burning or warming of the skin up to 45°C
Acupressure

Cryopuncture Cooling and slight freezing of the skin in the region of the acupuncture point thereby influencing thermo-receptors and a non-specific cryodestructive effect is obtained Medicamentous acupuncture This method injects pharmaceuticals, vitamins, phytoproducts, procaine and other materials, most often in the given acu-point Auto-hemopuncture The patient’s own blood is injected subcutaneously into the region of the acu-point Apitherapy Bee honey is inserted in the region of the acupuncture point on the skin Cupping

Magnito-puncture Acupuncture point that is influenced by magnetic fields Laser acupuncture Other methods

(Source: adapted from Iliev)262

Acupuncture includes original acupuncture (acus-puncture) and many related methods such as the use of moxibustion, cupping, acupressure and can be divided according to the use or absence of needles.262

Acne

Acupuncture for acne has been reported in a review of TCM applications.263 A recent small study with He–Ne laser auricular irradiation plus body acupuncture for acne vulgaris reported a significant benefit.264 The results showed that the cure rate was approximately 80% in the treatment group and 47% in the control group indicating that He–Ne laser auricular irradiation plus body acupuncture may exhibit better effects for acne vulgaris.

A recent RCT from China that investigated 26 patients with acne conglobata treated by encircling acupuncture combined with ventouse and cupping demonstrated efficacy.265 The study concluded that both acupuncture and medication effectively promoted the recovery of the affected skin, and lowered serum IL-6 levels in acne conglobata patients. The effect of acupuncture was stronger than that of isotretinoin in lowering serum IL-6 content and was associated with fewer adverse effects.

A review article also from China has concluded that acupuncture–moxibustion was safe and effective for treatment of acne, and that it was possibly better than routine Western medicine. Moreover, that the comprehensive acupuncture–moxibustion therapy was better than single acupuncture–moxibustion therapy.266 These data need to be further evaluated.267

The effectiveness of pharmaceutical therapies for acne has discouraged the use of acupuncture, however, in those individuals who have a history of drug allergy or intolerance, needle acupuncture may still be useful.

Psoriasis

An early study progressed the use of acupuncture as a treatment option for psoriasis.270 Using filiform needle acupuncture to stimulate a number of key points and related acu-points, this study investigated 61 patients with psoriasis who had poor response to Western medical management. Subsequent to an average of 9 sessions of acupuncture treatment, approximately 50% of the 61 patients had complete or near-complete clearance of their skin lesions, approximately one-third had partial improvement, and 15% did not improve. This study’s results are weakened by the lack of a control group however, the results were considered important at the time.

A subsequent Swedish study reported that classical needle acupuncture was not superior to sham therapy in the treatment of psoriasis.271 Though methodologically more robust, the primary weakness of this study was its lack of description in terms of acupuncture points and techniques employed. In addition, the sample size was small with 35 participants receiving acupuncture, and 19 receiving sham acupuncture.

A recent multi-centre study from China and review of the literature has reported that the meridian three-combined therapy was effective and safe for treatment of ordinary psoriasis.272 Hence, this multi-centre, randomised and positive drug controlled trial consisted of 233 cases that were divided into an observation group of 116 cases and a control group of 117 cases. The observation group was treated with thread embedding at points, blood-letting puncture on the back of the ear and auricular point pressing (i.e. meridian three-combined therapy).

Urticaria

Acupuncture has been reported to be effective for both acute and chronic urticaria.275

A recent study from China has reported that acupuncture had a benign regulatory effect on IgE, showing a favourable regulation on the immune functions in patients with chronic urticaria.276

A subsequent study also from China investigated the therapeutic effects of acupuncture plus point-injection for obstinate urticaria.277 Sixty-four cases of obstinate urticaria were randomly divided into 2 groups. The results demonstrated that the therapeutic effect in the treatment group was significantly better than that in the control group, with a much lower relapse rate in the test group than in the control group.

Vitiligo

Briefly vitiligo is a chronic disorder that causes de-pigmentation in patches of skin. A recent study utilising low-energy He–Ne laser therapy induced re-pigmentation and improved the appearance of the skin in segmental vitiligo.278 After an average of 17 treatment sessions, initial re-pigmentation was noticed in the majority of patients. Marked re-pigmentation (> 50%) was observed in 60% of the patients with successive treatments. Furthermore cutaneous blood flow was significantly higher at segmental vitiligo lesions compared with contralateral skin, but this was normalised after He–Ne laser treatment. The study concluded that He–Ne laser therapy was an effective treatment for segmental vitiligo by normalising dysfunctions of cutaneous blood flow and adrenoceptor responses in these patients. It was hypothesized that the beneficial effects of He–Ne laser therapy could be mediated in part by a reparative effect on sympathetic nerve dysfunction.

Conclusion

General practice dermatology refers to the assessment, treatment and referral of disorders affecting the skin, nail, hair or mucous membranes. Skin topography and microvasculature undergo characteristic changes with ageing as well as with environmental exposures. Hence there are important implications for clinical practice and research of skin diseases. There are a number of studies that are appropriate for the integrative management of the patient with skin diseases given that there is a significant amount of evidence of extensive CAM use among patients with skin diseases.

Common sense suggests that studies of food allergy exclusions should be carried out on people with a history of suggested food allergy, confirmed by appropriate allergy testing or challenge tests. A distinction should be made between young children, grown-up children and adults, because food allergy in children tends to improve over time. Disease severity should be measured using valid instruments and include quality of life assessments such as adherence to prudent physical activity regimens, nutritional practices and life stressors so that patient-centred outcomes can be interpreted clinically.

Also, it should be noted that CAM products are also extensively used by people to improve skin appearance as a form of anti-ageing therapy. A large number of complementary medicine therapies have been advocated for skin as cosmeceuticals. Commercial anti-ageing creams can contain 1 or more of the following:

Hence clinicians need to be aware of the plethora of compounds that may find their way into skin products that may be effective or alternatively that may cause irritability to the skin or perhaps may have the potential to be toxic (e.g. idebenone).

Table 14.9 summarises the level of evidence for some CAM therapies for eczema, psoriasis and other skin disorders.

Clinical tips handout for patients–skin diseases

5 Dietary changes

7 Supplements

Herbal medicines (all for external/topical use only)

Word of caution: always patch-test a small area of skin to check sensitivity before wider application. Take great care with babies and infants — apply to smaller areas after a test dose (patch-test). Immediately cease using a product if it causes pain, redness, itchiness, burning, or any irritation of the skin. Avoid contact with eyes. Not for oral ingestion.

A number of herbal medicines have been researched and promoted for topical use and these include the following.

Tea tree oil

Typically, preparations contain about 4–5% tea tree oil and are used daily for 4 weeks to 6 months depending on condition.

References

1 Mukhtar H., Mercurio M.G., Agarwal R. Murine skin carcinogenesis: Relevance to humans. In: Mukhtar H., editor. Skin Cancer: Mechanism and Human Relevance. Boca Raton: CRC Press; 1995:3-8.

2 Blanpain C., Fuchs E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol. 2009;10(3):207-217.

3 Bickers D.R., Lim H.W., Margolis D., et al. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol. 2006;55:490-500.

4 Khatami M. San Sebastian Skin Disease: A Neglected Public Health Problem. Dermatologic Clinics. 2007;27(2):99-101.

5 Wolkenstein P., Grob J.J., Bastuji-Garin S., et al. Societe Francaise de Dermotologie. French people and skin diseases: results of a survey using a representative sample. Arch Dermat. 2003;139:1614-1619.

6 Figueroa J.I., Fuller L.C., Abraha A., et al. Dermatology in the south western Ethiopia: rational for a community approach. Int J Dermatol. 1998;37:752-758.

7 Chen S.C., Bayoumi A.M., Soon S.L., et al. A catalogue of dermatology utilities: a measure of the burden of skin diseases. J Investig Dermatol Symp Proc. 2004;9:160-168.

8 Insinga R.P., Dasbach E.J., Elbasha E.H., et al. Assessing the annual economical burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature. Pharmacoeconomics. 2005;23:1107-1122.

9 Walker N., Lewis-Jones M.S. Quality of life and acne in Scottish adolescent schoolchildren: use of the Children’s Dermatology Life Quality Index (CDLQI) and the Cardiff Acne Disability Index (CADI). J Eur Acad Dermatol Venereol. 2006;20:45-50.

10 Carroll C.L., Balkrishnan R., Feldman S.R., et al. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol. 2005;22:192-199.

11 Bickers D.R., Lim H.W., Margolis D., et al. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol. 2006;55(3):490-500.

12 Linnane A.W., Kios M., Vitetta L. Healthy ageing: regulation of the metabolome by cellular redox modulation and prooxidant signaling systems: the essential roles of superoxide anion and hydrogen peroxide. Biogerontology. 2007;8(5):445-467.

13 Verhoeven E.W., Kraaimaat F.W., van Weel C., et al. Skin diseases in family medicine: prevalence and health care use. Ann Fam Med. 2008;6(4):349-354.

14 Morganti P. The photoprotective activity of nutraceuticals. Clin Dermatol. 2009;27(2):166-174.

15 Just-Sarobé M. Smoking and the Skin. Actas Dermosifiliogr. 2008;99:173-184.

16 Morita A. Tobacco smoke causes premature skin ageing. J Dermatol Sci. 2007;48(3):169-175.

17 Frances C. Smoker’s wrinkles: epidemiological and pathogenic considerations. Clin Dermatol. 1998;16:565-570.

18 Ernster V.L., Grady D., Miike R., et al. Facial wrinkling in men and women, by smoking status. Am J Public Health. 1995;85:78-82.

19 Grady D., Ernster V. Does cigarette smoking make you ugly and old? Am J Epid. 1992;135:839-842.

20 Kadunce D.P., Burr R., Gress R., et al. Cigarette smoking: risk factor for premature facial wrinkling. Ann Intern Med. 1991;114:840-844.

21 Wenk J., Brenneisen P., Meewes C., et al. UV-induced oxidative stress and photo-ageing. Curr Probl Dermatol. 2001;29:83-94.

22 Fisher G.J., Talwar H.S., Lin J., et al. Molecular mechanisms of photo-ageing in human skin in vivo and their prevention by all-trans retinoic acid. Photochem Photobiol. 1999;69:154-157.

23 Grether-Beck S., Buettner R., Krutmann J. Ultraviolet A radiation-induced expression of human genes: molecular and photobiological mechanisms. Biol Chem. 1997;378:1231-1236.

24 Leung W.-C., Harvey I. Is skin ageing in the elderly caused by sun exposure or smoking? Br J Dermatol. 2002;147:1187-1191.

25 Kostović K., Lipozencić J. Skin diseases in alcoholics. Acta Dermatoven Croat. 2004;12(3):181-190.

26 Peters E.M., Kuhlmei A., Tobin D.J., et al. Stress exposure modulates peptidergic innervation and degranulates mast cells in murine skin. Brain Behav Immun. 2005;19:252-262.

27 Joachim R.A., Sagach V., Quarcoo D., et al. Neurokinin-1 receptor mediates stress-exacerbated allergic airway inflammation and airway hyperresponsiveness in mice. Psych Med. 2004;66:564-571.

28 Buljan D., Buljan M., Zivkovic M.V., et al. Basic aspects of psychodermatology. Psychiatr Danub. 2008;20(3):415-418.

29 Hashisume H., Horibe T., Ohshima A., et al. Anxiety accelerates T-helper 2-tilted immune responses in patients with atopic dermatitis. Br J Dermatol. 2005;152:1161-1164.

30 Kilpelainen M., Koskenvuo M., Helenius H., Terho E.O. Stressful life events promote the manifestation of asthma and atopic diseases. Clin Exp Allergy. 2002;32:256-263.

31 Kodama A., Horikawa T., Suzuki T., et al. Effect of stress on atopic dermatitis: investigation in patients after the great hanshin earthquake. J Allergy Clin Immunol. 1999;104:173-176.

32 Buske-Kirschbaum A., Geiben A., Hellhammer D. Psychobiological aspects of atopic dermatitis: an overview. Psychother Psychosom. 2001;70:6-16.

33 Arndt J., Smith N., Tausk F. Stress and atopic dermatitis. Curr Allergy Asthma Rep. 2008;8(4):312-317.

34 Hendrix S. Neuroimmune Communication in Skin: Far from Peripheral. J Invest Dermatol. 2008;128:260-261.

35 Christian L.M., Graham J.E., Padgett D.A., et al. Stress and wound healing. Neuroimmunomodulation. 2006;13(5-6):337-346.

36 Godbout J.P., Glaser R. Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer. J Neuroimmune Pharmacol. 2006;1(4):421-427.

37 Verhoeven E.W., de Klerk S., Kraaimaat F.W., et al. Biopsychosocial mechanisms of chronic itch in patients with skin diseases: a review. Acta Derm Venereol. 2008;88(3):211-218.

38 Nolan B.V., Feldman S.R. Ultraviolet tanning addiction. Dermatol Clin. 2009;27:109-112.

39 Gaudy-Marqueste C., Madjlessi N., Guillot B., et al. Risk factors in elderly people for lentigo maligna compared with other melanomas: a double case-control study. Arch Dermatol. 2009;145(4):418-423.

40 Kennedy C., Bajdik C.D., Willemze R., et al. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol. 2003;120(6):1087-1093.

41 Armstrong B.K., Kricker A. How much melanoma is caused by sun exposure? Melanoma Res. 1993;3:395-401.

42 Taylor C.R., Sober A.J. Sun exposure and skin disease. Annu Rev Med. 1996;47:181-191.

43 Skin Cancer Fact Sheet – from American Academy of Dermatology. Online. Available: http://www.aad.org/media/background/factsheets/fact_skincancer.html (accessed June 2009).

44 Young A.R. Cumulative effects of ultraviolet radiation in the skin: cancer and photo-ageing. Semin Dermatol. 1990;1990(9):25-31.

45 Engel A., Johnson M.L., Haynes S.G. Health effects of sunlight exposure in the United States. Arch Dermatol. 1988;124:72-79.

46 de Groot A.C., Bruynzeel D.P., Bos J.D., et al. The allergens in cosmetics. Arch Dermatol. 1988;124:1525-1529.

47 Goossens A., Beck M.H., Haneke E., McFadden J.P., et al. Adverse cutaneous reactions to cosmetic allergens. Contact Dermatitis. 1999;40:112-113.

48 Nielsen N.H., Linneberg A., Menne T., et al. Allergic contact sensitisation in an adult Danish population: two cross-sectional surveys eight years apart (the Copenhagen Allergy Study). Acta Derm Venereol. 2001;81:31-34.

49 Ortis K.J., Yiannias J.A. Contact dermatitis to cosmetics, fragrances, and botanicals. Dermatol Ther. 2004;17(3):264-271.

50 Orton D.I., Wilkinson J.D. Cosmetic allergy: incidence, diagnosis, and management. Am J Clin Dermatol. 2004;5(5):327-337.

51 Fried R.G., Gupta M.A., Gupta A.K. Depression and skin disease. Dermatol Clin. 2005;23(4):657-664.

52 Shenefelt P.D. Therapeutic management of psychodermatological disorders. Expert Opin Pharmacother. 2008;9(6):973-985.

53 Tausk F.A. Alternative medicine: is it all in your mind? Arch Dermatol. 1998;134:1422-1425.

54 Shenefelt P.D. Hypnosis in dermatology. Arch Dermatol. 2000;136:393-399.

55 Spiegel H., Spiegel D. Trance and treatment: clinical uses of hypnosis, 2nd edn. Washington: DC7 American Psychiatric Publishing; 2004. 51–92

56 Shenefelt P.D. Therapeutic management of psychodermatological disorders. Expert Opin Pharmacother. 2008;9(6):973-985.

57 Sarti M.G. Biofeedback in dermatology. Clin Dermatol. 1998;16(6):711-714.

58 Freedman R.R. Quantitative measurements of finger blood flow during behavioural treatments for Raynaud’s disease. Psychophysiology. 1989;26(4):437-441.

59 Ersser S.J., Latter S., Sibley A., et al. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev. (3):2007 Jul 18. CD004054

60 Bilkis M.R., Mark K.A. Mind-body medicine. Practical applications in dermatology. Arch Dermatol. 1998;134(11):1437-1441.

61 Ospina M.B., Bond K., Karkhaneh M., et al. Meditation practices for health: state of the research. Evid Rep Technol Assess (Full Rep), 2007;(155):1-263.

62 Javnbakht M., Hejazi Kenari R., Ghasemi M. Effects of yoga on depression and anxiety of women. Complement Ther Clin Pract. 2009;15(2):102-104.

63 Grodin M.A., Piwowarczyk L., Fulker D., et al. Treating survivors of torture and refugee trauma: a preliminary case series using qigong and t’ai chi. J Altern Complement Med. 2008;14(7):801-806.

64 Kuramoto A.M. Therapeutic benefits of Tai Chi exercise: research review. WMJ. 2006;105(7):42-46.

65 Wall R.B. Teaching Tai Chi with mindfulness-based stress reduction to middle school children in the inner city: a review of the literature and approaches. Med Sport Sci. 2008;52:166-172.

66 Dattner A.M. Nutritional dermatology. Clin Dermatol. 1999;17(1):57-64.

67 Guin J.D., Hoskyn J. Aggravation of rosacea by protein contact dermatitis to soy. Contact Dermatitis. 2005;53(4):235-236.

68 Humbert P., Pelletier F., Dreno B., et al. Gluten intolerance and skin diseases. Eur J Dermatol. 2006;16(1):4-11.

69 Ackland M.L., Michalczyk A. Zinc deficiency and its inherited disorders –a review. Genes Nutr. 2006;1(1):41-49.

70 Lee B.Y., Thurmon T.F. Nutritional disorders among workers in North China during national turmoil. Ann Nutr Metab. 2001;45(4):175-180.

71 Sicherer S.H., Leung D.Y. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2008. J Allergy Clin Immunol. 2009;123(2):319-327.

72 Lack G. Epidemiologic risks for food allergy. J Allergy Clin Immunol. 2008;121:1331-1336.

73 Untersmayr E., Jensen-Jarolim E. The role of protein digestibility and antacids on food allergy outcomes. J Allergy Clin Immunol. 2008;121:1301-1308.

74 Pistiner M., Gold D.R., Abdulkerim H., et al. Birth by caesarean section, allergic rhinitis, and allergic sensitisation among children with a parental history of atopy. J Allergy Clin Immunol. 2008;122:274-279.

75 Hare N.D., Fasano M.B. Clinical manifestations of food allergy: differentiating true allergy from food intolerance. Postgrad Med. 2008;120(2):E01-E05.

76 Chandra R.K. Food hypersensitivity and allergic diseases. Eur J Clin Invest. 2002;56:S54-S56.

77 Sampson H.A. The evaluation and management of food allergy in atopic dermatitis. Clin Dermatol. 2003;21:183-192.

78 Bath-Hextall F., Delamere F.M., Williams H.C. Dietary exclusions for improving established atopic eczema in adults and children: systematic review. Allergy. 2009;64(2):258-264.

79 Eaton S.B., Konner M. Paleolithic nutrition; A consideration of its nature and current implications. NEJM. 1985;312:283-289.

80 Smith R.N., Mann N.J., Braue A., et al. The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomised, investigator-masked, controlled trial. J Am Acad Dermatol. 2007;57(2):247-256.

81 Smith R.N., Mann N.J., Braue A., et al. A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomised controlled trial. Am J Clin Nutr. 2007;86(1):107-115.

82 Berra B., Riszo A.M. Glycemic index, glycemic load, wellness and beauty: the state of the art. Clin Dermatol. 2009;27(2):230-235.

83 Thomas D.E., Elliott E.J., Baur L. Low glycaemic index or low glycaemic load diets for overweight and obesity. Cochrane Database Syst Rev. (3):2007. CD005105

84 Smith R.N., Braue A., Varigos G.A., Mann N.J. The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin surface triglycerides. J Dermatol Sci. 2008;50(1):41-52.

85 Bath-Hextall F., Delamere F.M., Williams H.C. Dietary exclusions for established atopic eczema. Cochrane Database Syst Rev. (1):2008 Jan 23. CD005203

86 Bath-Hextall F., Delamere F.M., Williams H.C. Dietary exclusions for improving established atopic eczema in adults and children: systematic review. Allergy. 2009;64(2):258-264.

87 Richelle M., Sabatier M., Steiling H., et al. Skin bioavailability of dietary vitamin E, carotenoids, polyphenols, vitamin C, zinc and selenium. Br J Nutr. 2006;96(2):227-238.

88 Kligman A.M., Fulton J.E., Plewig G. Topical vitamin A acid in acne vulgaris. Arch Dermatol. 1969;99:469-476.

89 Kligman A.M., Mills O.H.Jr., Leyden J.J., et al. Oral vitamin A in acne vulgaris. Preliminary report. Int J Dermatol. 1981;20:278-285.

90 Kligman A.M. The growing importance of topical retinoids in clinical dermatology: A retrospective and prospective analysis. J Am Acad Dermatol. 1998;39:S2-S7.

91 Hunt T.K. Vitamin A and wound healing. J Am Acad Dermatol. 1986;15:817-821.

92 Saurat J.H. Retinoids. In: Katsambas A.D., Lotti T.M., editors. European handbook of dermatologic treatments. Berlin, Heidelberg: Springer-Verlag; 1999:812-818.

93 Fritsch P.O. Retinoids in psoriasis and disorders of keratinisation. J Am Acad Derm. 1992;27:S8-14.

94 Goldsmith L.A., Weinrich A.E., Shupack J. Pityriasis rubra pilaris response to 13- cis-retinoic acid (isotretinoin). J Am Acad Dermatol. 1982;6(Suppl):710-715.

95 Levine N. Role of retinoids in skin cancer treatment and prevention. J Am Acad Dermatol. 1998;39:S62-S66.

96 Katsambas A.D., Lotti T.M. Melasma. In: Katsambas A.D., Lotti T.M., editors. European handbook of dermatologic treatments. Berlin, Heidelberg: Springer-Verlag; 1999:368-373.

97 Laszlo Keller K., Fenske N.A. Uses of vitamins A, C, and E and related compounds in dermatology: A review. J Am Acad Dermatol. 1998;39:611-625.

98 Kraemer K.H., DiGiovanna J.J., Moshell A.N., et al. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. NEJM. 1998;318:1633-1637.

99 Goldberg L.H., Hsu S.H., Alcalay J. Effectiveness of isotretinoin in preventing the appearance of basal cell carcinomas in basal cell nevus syndrome. J Am Acad Dermatol. 1989;21:144-145.

100 DiGiovanna J.J. Retinoid chemoprevention in the high-risk patient. J Am Acad Dermatol. 1998;39:S82-S85.

101 Moon T.E., Levine N., Cartmel B., et al. Effect of retinol to prevent squamous cell skin cancer in moderate-risk subjects. Cancer Epidemiol Biomarkers Prev. 1997;6:949-956.

102 Levine N., Moon T.E., Cartmel B., et al. Trial of retinol and isotretinoin in skin cancer prevention. Cancer Epidemiol Biomarkers Prev. 1997;6:957-961.

103 Haydey R.P., Reed M.L., Dzubow L.M., et al. Treatment of keratoacanthomas with oral 13- cis-retinoic acid. NEJM. 1980;303:560-562.

104 Benoldi D., Alinovi A. Multiple persistent keratoacanthomas: Treatment with oral etretinate. J Am Acad Dermatol. 1984;10:1035-1038.

105 Lippman S.M., Meyskens F.L.Jr. Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann Intern Med. 1987;107:499-502.

106 Sies H., Stahl W. Nutritional protection against skin damage from sunlight. Annu Rev Nutr. 2004;24:173-200.

107 Dreher F., Maibach H. Protective effects of topical antioxidants in humans. Curr Probl Dermatol. 2001;29:157-164.

108 Oresajo C., Stephens T., Hino P.D., et al. Protective effects of a topical antioxidant mixture containing vitamin C, ferulic acid, and phloretin against ultraviolet-induced photodamage in human skin. J Cosmet Dermatol. 2008;7(4):290-297.

109 Darr D., Dunston S., Faust H., et al. Effectiveness of antioxidants (vitamin C and E) with and without sunscreens as topical photoprotectants. Acta Derm Venereol (Stockh). 1996;76:264-268.

110 Eberlein-Konig B., Placzek M., Przybilla B. Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol (vitamin E). J Am Acad Dermatol. 1998;38:45-48.

111 Dunham W.B., Zuckerkandl E., Reynolds R., et al. Effects of intake of l-ascorbic acid on the incidence of dermal neoplasms induced in mice by ultraviolet light. PNAS. 1982;79:7532-7536.

112 Pauling L. Effect of ascorbic acid on incidence of spontaneous mammary tumors and UV-light-induced skin tumors in mice. Am J Clin Nutr. 1991;54(6 Suppl):S1252-S1255.

113 Oresajo C., Stephens T., Hino P.D., et al. Protective effects of a topical antioxidant mixture containing vitamin C, ferulic acid, and phloretin against ultraviolet-induced photodamage in human skin. J Cosmet Dermatol. 2008;7(4):290-297.

114 Samuel M., Brooke R.C., Hollis S., et al. Interventions for photodamaged skin. Cochrane Database Syst Rev. 25, 2005. CD001782. Review

115 Farris P.K. Topical vitamin C: a useful agent for treating photo-ageing and other dermatologic conditions. Dermatol Surg. 2005;31(7 Pt 2):814-817.

116 Catani M.V., Savini I., Rossi A., et al. Biological role of vitamin C in keratinocytes. Nutr Rev. 2005 Mar;63(3):81-90.

117 Lévêque N., Mac-Mary S., Muret P., et al. Evaluation of a sunscreen photoprotective effect by ascorbic acid assessment in human dermis using microdialysis and gas chromatography mass spectrometry. Exp Dermatol. 2005;14(3):176-181.

118 Placzek M., Gaube S., Kerkmann U., et al. Ultraviolet B-induced DNA damage in human epidermis is modified by the antioxidants ascorbic acid and D-alpha-tocopherol. J Invest Dermatol. 2005;124(2):304-307.

119 McVean M., Liebler D.C. Inhibition of UVB-induced DNA photodamage in mouse epidermis by topically applied alpha-tocopherol. Carcinogenesis. 1997;18:1617-1622.

120 Trevithick J.R., Xiong H., Lee S., et al. Topical tocopherol acetate reduces post-UVB sunburn-associated erythema, edema, and skin sensitivity in hairless mice. Arch Biochem Biophys. 1992;296:575-582.

121 Bissett D.L., Chatterjee R., Hannon D.P. Photoprotective effect of superoxide-scavenging antioxidants against ultraviolet radiation-induced chronic skin damage in the hairless mouse. Photodermatol Photoimmunol Photomed. 1990;7:56-62.

122 Werninghaus K., Meydani M., Bhawan J., et al. Evaluation of the photoprotective effect of oral vitamin E supplementation. Arch Dermatol. 1994;130:1257-1261.

123 Thiele J.J., Hsieh S.N., Ekanayake-Mudiyanselage S., Vitamin E. critical review of its current use in cosmetic and clinical dermatology. Dermatol Surg. 2005;31(7 Pt 2):805-813.

124 Starasoler S., Haber G.S. Use of vitamin E oil in primary herpes gingivostomatitis in an adult. N Y State Dent J. 1978;44:382-383.

125 Nead D.E. Effective vitamin E treatment for ulcerative herpetic lesions. Dent Surv. 1976;52:50-51.

126 Fink M., Fink J. Treatment of Herpes simplex by alpha-tocopherol (vitamin E). Br Dent J. 1980;148:246.

127 Mason A.R., Mason J., Cork M., et al. Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev. (2):2009 Apr 15. CD005028

128 de Korte J., van der Valk P.G., Sprangers M.A., et al. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomised controlled trial of supervised treatment of psoriasis in a day-care setting. Br J Dermatol. 2008;158(2):375-381.

129 Lebwohl M., Ortonne J.P., Andres P., et al. Calcitriol ointment 3 microg/g is safe and effective over 52 weeks for the treatment of mild to moderate plaque psoriasis. Cutis. 2009;83(4):205-212.

130 Sidbury R., Sullivan A.F., Thadhani R.I., et al. Randomised controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br J Dermatol. 2008;159:245-247.

131 Anderson P.C., Dinulos J.G. Atopic dermatitis and alternative management strategies. Curr Opin Pediatr. 2009;21(1):131-138.

132 Holick M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81:353-373.

133 Berwick M., Armstrong B.K., Ben-Porat L., et al. Sun exposure and mortality from melanoma. JNCI. 2005;97:195-199.

134 Boniol M., Armstrong B.K., Dore J.F. Variation in incidence and fatality of melanoma by season of diagnosis in New South Wales, Australia. Cancer Epidemiol Biomarkers Prev. 2006;15:524-526.

135 Porojnicu A.C., Dahlback A., Moan J. Sun exposure and cancer survival in Norway: changes in the risk of death with season of diagnosis and latitude. Adv Exp Med Biol. 2008;624:43-54.

136 Rosso S., Sera F., Segnan N., et al. Sun exposure prior to diagnosis is associated with improved survival in melanoma patients: results from a long-term follow-up study of Italian patients. Eur J Cancer. 2008;44:1275-1281.

137 Gandini S., Raimondi S., Gnagnarella P., et al. Vitamin D and skin cancer: A meta-analysis. Eur J Can. 2009;45:634-641.

138 Parish L.C., Sofman M.S., Chalker D.K. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. Int J Dermatol. 1995;34:434-437.

139 Handfield-Jones S., Jones S., Peachey R. High-dose nicotinamide in the treatment of necrobiosis lipoidica. Br J Dermatol. 1988;118:693-696.

140 Zemtsov A., Neldner K.H. Successful treatment of dermatitis herpetiformis with tetracycline and nicotinamide in a patient unable to tolerate dapsone. J Am Acad Dermatol. 1993;28:505-506.

141 Fivenson D.P., Breneman D.L., Rosen G.B., et al. Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol. 1994;130:753-758.

142 Ross J.B., Moss M.A. Relief of the photosensitivity of erythropoietic protoporphyria by pyridoxine. J Am Acad Dermatol. 1990;22:340-342.

143 Juhlin L., Olsson M.J. Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure. Acta Derm Venereol (Stockh). 1997;77:460-462.

144 Prasad A.S. Zinc deficiency. BMJ. 2003;326:409-410.

145 Michaelsson G., Vahlquist A., Juhlin L. Serum zinc and retinol-binding protein in acne. Br J Dermatol. 1977;96:283-286.

146 Amer M., Bahgat M.R., Tosson Z., et al. Serum zinc in acne vulgaris. Int J Dermatol. 1982;21:481-484.

147 Hillstrom L., Pettersson L., Hellbe L., et al. : Comparison of oral treatment with zinc sulphate and placebo in acne vulgaris. Br J Dermatol. 1977;97:681-684.

148 Michaelsson G., Juhlin L., Vahlquist A. Effects of oral zinc and vitamin A in acne. Arch Dermatol. 1977;113:31-36.

149 Goransson K., Liden S., Odsell L. Oral zinc in acne vulgaris: A clinical and methodological study. Acta Derm Venereol. 1978;58:443-448.

150 Verma K.C., Saini A.S., Dhamija S.K. Oral zinc sulphate therapy in acne vulgaris: A double-blind trial. Acta Derm Venereol. 1980;60:337-340.

151 Liden S., Goransson K., Odsell L. Clinical evaluation in acne. Acta Derm Venereol Suppl (Stockh). 1980;89:47-52.

152 Dreno B., Amblard P., Agache P., et al. Low doses of zinc gluconate for inflammatory acne. Acta Derm Venereol. 1989;69:541-543.

153 Dreno B., Moyse D., Alirezai M., et al. Multicenter randomised comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology. 2001;203:135-140.

154 Orris L., Shalita A.R., Sibulkin D., et al. Oral zinc therapy of acne. Absorption and clinical effect. Arch Dermatol. 1978;114:1018-1020.

155 Weimar V.M., Puhl S.C., Smith W.H., et al. Zinc sulfate in acne vulgaris. Arch Derm. 1978;114:1776-1778.

156 Cochran R.J., Tucker S.B., Flannigan S.A. Topical zinc therapy for acne vulgaris. Int J Dermatol. 1985;24:188-190.

157 Schachner L., Eaglstein W., Kittles C., et al. Topical erythromycin and zinc therapy for acne. J Am Acad Dermatol. 1990;22:253-260.

158 Schachner L., Pestana A., Kittles C. A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation. J Am Acad Dermatol. 1990;22:489-495.

159 Van Hoogdalem E.J., Terpstra I.J., Baven A.L. Evaluation of the effect of zinc acetate on the stratum corneum penetration kinetics of erythromycin in healthy male volunteers. Skin Pharm. 1996;9:104-110.

160 Orris L., Shalita A.R., Sibulkin D., et al. Oral zinc therapy of acne. Absorption and clinical effect. Arch Dermatol. 1978;114:1018-1020.

161 Guthery E., Seal L.A., Anderson E.L. Zinc pyrithione in alcohol-based products for skin antisepsis: persistence of antimicrobial effects. Am J Infect Control. 2005;33(1):15-22.

162 Pence B.C., Delver E., Dunn D.M. Effects of dietary selenium of UVB-induced skin carcinogenesis and epidermal antioxidant status. J Invest Dermatol. 1994;102:759-761.

163 Clark L.C., Graham G.F., Crounse R.G., et al. Plasma selenium and skin neoplasms: A case control study. Nutr Cancer. 1984;6:13-21.

164 Combs G.F.Jr., Clark L.C., Turnbull B.W., et al. Low plasma selenium predicts the 24-month incidence of squamous cell carcinoma of the skin in a cancer prevention trial. FASEB J. 1993;7:A278.

165 Clark L.C., Combs G.F.Jr., Turnbull B.W., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomised controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996;276:1957-1963.

166 Bath-Hextall F., Leonardi-Bee J., Somchand N., et al. Interventions for preventing non-melanoma skin cancers in high-risk groups. Cochrane Database Syst Rev. (4):2007 Oct 17. CD005414

167 Dreno B., Euvrard S., Frances C., et al. Effect of selenium intake on the prevention of cutaneous epithelial lesions in organ transplant recipients. Eur J Dermatol. 2007;17(2):140-145.

168 Berger M.M., Binnert C., Chiolero R.L., et al. Trace element supplementation after major burns increases burned skin trace element concentrations and modulates local protein metabolism but not whole-body substrate metabolism. AJCN. 2007;85(5):1301-1306.

169 Berger M.M., Baines M., Raffoul W., et al. Trace element supplementation after major burns modulates antioxidant status and clinical course by way of increased tissue trace element concentrations. AJCN. 2007;85(5):1293-1300.

170 Dreno B., Nocera T., Verriere F., et al. Topical retinaldehyde with glycolic acid: Study of tolerance and acceptability in association with anti-acne treatments in 1,709 patients. Dermatology. 2005;210:22-29.

171 Poli F., Ribet V., Lauze C., et al. Efficacy and safety of 0.1% retinaldehyde/6% glycolic acid (diacneal) for mild to moderate acne vulgaris. A multicentre, double-blind, randomised, vehicle-controlled trial. Dermatology. 2005;210:14-21.

172 Tran C., Kasraee B., Grand D., et al. Pharmacology of RALGA, a mixture of retinaldehyde and glycolic acid. Dermatology. 2005;210:6-13.

173 Katsambas A.D. RALGA (Diacneal), a retinaldehyde and glycolic acid association and postinflammatory hyperpigmentation in acne—a review. Dermatology. 2005;210:39-45.

174 Hunt M.J., Barnetson R.S. A comparative study of gluconolactone versus benzoyl peroxide in the treatment of acne. Australas J Dermatol. 1992;33(3):131-134.

175 Joshi S.S., Boone S.L., Alam M., et al. Effectiveness, safety, and effect on quality of life of topical salicylic acid peels for treatment of postinflammatory hyperpigmentation in dark skin. Dermatol Surg. 2009;35(4):638-644.

176 Bissonnette R., Bolduc C., Seite S., et al. Randomised study comparing the efficacy and tolerance of a lipophillic hydroxyl acid derivative of salicylic acid and 5% benzoyl peroxide in the treatment of facial acne vulgaris. J Cosmet Dermatol. 2009;8(1):19-23.

177 Hoppe U., Bergemann J., Diembeck W., et al. Coenzyme Q10, a cutaneous antioxidant and energiser. Biofactors. 1999;9(2-4):371-378.

178 Shapiro S.S., Saliou C. Role of vitamins in skin care. Nutrition. 2001;17(10):839-844.

179 Kharaeva Z., Gostova E., De Luca C., et al. Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients. Nutrition. 2009;25(3):295-302.

180 Blatt T., Lenz H., Koop U., et al. Stimulation of skin’s energy metabolism provides multiple benefits for mature human skin. Biofactors. 2005;25(1-4):179-185.

181 Puisina-Ivic N. Skin ageing. Acta Dermatovenerol Alp Panonica Adriat. 2008;17(2):47-54.

182 Podda M., Grundmann-Kollmann M. Low molecular weight antioxidants and their role in skin ageing. Clin Exp Dermatol. 2001;26(7):578-582.

183 Caramia G., Atzei A., Fanos V. Probiotics and the skin. Clin Dermatol. 2008;26(1):4-11.

184 Krutmann J. Pre- and probiotics for human skin. J Dermatol Sci. 2009;54(1):1-5.

185 von Hertzen L.C., Savolainen J., Hannuksela M., et al. Scientific rationale for the Finnish Allergy Program 2008-2018: emphasis on prevention and endorsing tolerance. Allergy. 2009;64:678-701.

186 Lee J., Seto D., Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol. 121, 2008. 116.e11–121.e11

187 Nicol N.H., Boguniewicz M.. Successful strategies in atopic dermatitis management. Dermatol Nurs. 2008;Suppl:3-18..

188 Boyle R.J., Bath-Hextall F.J., Leonardi-Bee J., et al. Probiotics for treating eczema. Cochrane Database Syst Rev. (4):2008 Oct 8. CD006135

189 Boyle R.J., Bath-Hextall F.J., Leonardi-Bee J., et al. Probiotics for the treatment of eczema: a systematic review. Clin Exp Allergy. 2009 Jul 1. (Epub ahead of print)

190 Anandan C., Nurmatov U., Sheikh A. Omega 3 and 6 oils for primary prevention of allergic disease: systematic review and meta-analysis. Allergy. 2009;64(6):840-848.

191 Schnappinger M., Sausenthaler S., Linseisen J., et al. Fish consumption, allergic sensitisation and allergic diseases in adults. Ann Nutr Metab. 2009;54(1):67-74.

192 Olsen S.F., Osterdal M.L., Salvig J.D., et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry-based follow-up from a randomised controlled trial. AJCN. 2008;88(1):167-175.

193 Sala-Vila A., Miles E.A., Calder P.C. Fatty acid composition abnormalities in atopic disease: evidence explored and role in the disease process examined. Clin Exp Allergy. 2008;38(9):1432-1450.

194 Blumer N., Renz H. Consumption of omega3-fatty acids during perinatal life: role in immuno-modulation and allergy prevention. J Perinat Med. 2007;35(Suppl 1):S12-S18.

195 Jones CLA. Introduction. In: Herbs for Healthy Skin. Mushroom eBooks 2002. ISBN 1843190672.

196 Magin P.J., Adams J., Pond C.D., et al. Topical and oral CAM in acne: A review of the empirical evidence and a consideration of its context. Complem Ther Med. 2006;14:62-76.

197 Jain A., Basal E. Inhibition of Propionibacterium acnes-induced mediators of inflammation by Indian herbs. Phytomedicine. 2003;10(1):34-38.

198 Bedi M.K., Shenefelt P.D. Herbal therapy in dermatology. Arch Dermatol. 2002;138(2):232-242.

199 Gabler H. (100 years of Hamamelis ointment). Dtsch Apoth. 1978;30:202-204.

200 Erdelmeier C.A., Cinatl J.Jr., Rabenau H., et al. Antiviral and antiphlogistic activities of Hamamelis virginiana bark. Planta Med. 1996;62:241-245.

201 Bassett I.B., Pannowitz D.L., Barnetson R.S. A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. MJA. 1990;153(8):455-458.

202 Raman A., Weir U., Bloomfield S.F. Antimicrobial effects of tea-tree oil and its major components on Staphylococcus aureus, Staph. epidermidis and Propionibacterium acnes. Lett Appl Microbiol. 1995;21(4):242-245.

203 Ernst E., Huntley A. Tea tree oil: a systematic review of randomised clinical trials. Forsch Komplementarmed Klass Naturheilkd. 2000;7(1):17-20.

204 Martin K.W., Ernst E. Herbal medicines for treatment of bacterial infections: a review of controlled clinical trials. J Antimicrob Chemother. 2003;51(2):241-246.

205 Enshaieh S., Jooya A., Siadat A.H., et al. The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomised, double-blind placebo-controlled study. Indian J Dermatol Venereol Leprol. 2007;73(1):22-25.

206 Koh K.J., Pearce A.L., Marshman G., et al. Tea tree oil reduces histamine-induced skin inflammation. Br J Dermatol. 2002;147(6):1212-1217.

207 Bedi M.K., Shenefelt P.D. Herbal therapy in dermatology. Arch Dermatol. 2002;138:232-242.

208 Daniele C., Thompson Coon J., Pittler M.H., et al. Vitex agnus castus: a systematic review of adverse events. Drug Saf. 2005;28:319-332.

209 PDR for Herbal Medicines (4th edn). Thompson Healthcare Inc, Montvael NJ, 2007. ISBN 1-56363-678-6.

210 Klein A.D., Penneys N.S. Aloe vera. J Am Acad Dermatol. 1988;118:714-720.

211 Visuthikosol V., Chowchuen B., Sukwanarat Y., et al. Effect of aloe vera gel to healing of burn wound a clinical and histologic study. J Med Assoc Thai. 1995;78(8):403-409.

212 Maenthaisong R., Chaiyakunapruk N., Niruntraporn S., et al. The efficacy of aloe vera used for burn wound healing: a systematic review. Burns. 2007;33(6):713-718.

213 Vitetta L., Sali A. Treatments for damaged skin. AFP. 2006;37:501-502.

214 Langemo D.K., Hanson D., Anderson J., et al. Use of honey for wound healing. Adv Skin Wound Care. 2009;22(3):113-118.

215 Evans J., Flavin S. Honey: a guide for healthcare professionals. Br J Nurs. 17(15), 2008. S24, S26, S28–30

216 Jull A.B., Rodgers A., Walker N. Honey as a topical treatment for wounds. Cochrane Database Syst Rev. (4):2008 Oct 8. CD005083

217 McQuestion M. Evidence-based skin care management in radiation therapy. Semin Oncol Nurs. 2006;22(3):163-173.

218 Bolderston A., Lloyd N.S., Wong R.K., et al. Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-Based Care. The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline. Support Care Canc. 2006;14(8):802-817.

219 Pommier P., Gomez F., Sunyach M.P., et al. Phase III randomised trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol. 2004;22(8):1447-1453.

220 Kassab S., Cummings M., Berkovitz S., et al. Homeopathic medicines for adverse effects of cancer treatments. Cochrane Database Syst Rev. (2):2009 Apr 15. CD004845

221 Wolbling R.H., Leonhardt K. Local therapy of Herpes simplex with dried extract from Melissa officinalis. Phytomedicine. 1994;1:25-31.

222 Koytchev R., Alken R.G., Dundarov S. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis. Phytomedicine. 1999;6(4):225-230.

223 Fiore C., Eisenhut M., Krausse R., et al. Antiviral effects of Glycyrrhiza species. Phytother Res. 2008;22(2):141-148.

224 Satchell A.C., Saurajen A., Bell C., et al. Treatment of interdigital tinea pedis with 25% and 50% tea tree oil solution: a randomized, placebo-controlled, blinded study. Australas J Dermatol. 2002;43:175-178.

225 Tong M.M., Altman P.M., Barnetson R.S. Tea tree oil in the treatment of tinea pedis. Australas J Dermatol. 1992;33(3):145-149.

226 Buck D.S., Nidorf D.M., Addino J.G. Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. J Fam Pract. 1994;38(6):601-605.

227 Faoagali J., George N., Leditschke J.F. Does tea tree oil have a place in the topical treatment of burns? Burns. 1997;23(4):349-351.

228 Ledezma E., López J.C., Marin P., et al. Ajoene in the topical short-term treatment of tinea cruris and tinea corporis in humans. Randomised comparative study with terbinafine. Arzneimittelforschung. 1999;49(6):544-547.

229 Ledezma E., DeSousa L., Jorquera A., et al. Efficacy of ajoene, an organosulphur derived from garlic, in the short-term therapy of tinea pedis. Mycoses. 1996;39(9-10):393-395.

230 Atherton D.J., Sheehan M.P., Rustin M.H., et al. Treatment of atopic eczema with traditional Chinese medicinal plants. Pediatr Dermatol. 1992;9(4):373-375.

231 Sheehan M.P., Atherton D.J. A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol. 1992;126(2):179-184.

232 Sheehan M.P., Rustin M.H., Atherton D.J., et al. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet. 1992;340(8810):13-17.

233 Zhang H., Qu X. Advances in experimental studies on treatment of psoriasis by traditional Chinese medicine. J Tradit Chin Med. 2002;22(1):61-66.

234 Tse T.W. Use of common Chinese herbs in the treatment of psoriasis. Clin Exp Dermatol. 2003;28(5):469-475.

235 Zhang L.X., Bai Y.P., Song P.H., et al. Effect of Chinese herbal medicine combined with acitretin capsule in treating psoriasis of blood-heat syndrome type. Chin J Integr Med. 2009;15(2):141-144.

236 Syed T.A., Ahmad S.A., Holt A.H., et al. Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-controlled, double-blind study. Trop Med Int Health. 1996;1(4):505-509.

237 Vogler B.K., Ernst E. Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract. 1999;49(447):823-828.

238 Paulsen E., Korsholm L., Brandrup F. A double-blind, placebo-controlled study of a commercial Aloe vera gel in the treatment of slight to moderate psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2005;19(3):326-331.

239 Bernstein J.E., Parish L.C., Rapaport M., et al. Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. J Am Acad Dermatol. 1986;15(3):504-507.

240 Ellis C.N., Berberian B., Sulica V.I., et al. A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol. 1993;29(3):438-442.

241 Hautkappe M., Roisen M.F., Toledano A., et al. Review of the effectiveness of capsaicin for painful cutaneous disorders and neural dysfunction. Clin J Pain. 1998;14(2):97-106.

242 Schempp C.M., Windeck T., Hezel S., et al. Topical treatment of atopic dermatitis with St. John’s wort cream–a randomised, placebo controlled, double-blind half-side comparison. Phytomedicine. 2003;10(Suppl 4):31-37.

243 Stevensen C.J. Aromatherapy in dermatology. Clin Dermatol. 1998;16(6):689-694.

244 Gulliver W.P., Donsky H.J. A report on three recent clinical trials using Mahonia aquifolium 10% topical cream and a review of the worldwide clinical experience with Mahonia aquifolium for the treatment of plaque psoriasis. Am J Ther. 2005;12(5):398-406.

245 Alebiosu C.O., Ogunledun A., Ogunleye D.S. A report of clinical trial conducted on Toto ointment and soap products. JNMA. 2003;95:95-105.

246 Oyelami O.A., Onayemi O., Oladimeji F.A., et al. Clinical evaluation of Acalypha ointment in the treatment of superficial fungal skin diseases. Phytother Res. 2003;17(5):555-557.

247 Klovekorn W., Tepe A., Danesch U. A randomised, double-blind, vehicle-controlled, half-side comparison with a herbal ointment containing Mahonia aquifolium, Viola tricolor and Centella asiatica for the treatment of mild-to-moderate atopic dermatitis. Int J Clin Pharm Ther. 2007;45(11):583-591.

248 Orafidiya L.O., et al. Preliminary clinical tests on topical preparations of Ocimum gratissimum Linn Leaf essential oil for the treatment of acne vulgaris. Clin Drugs Under Invest. 2002;22(5):313-319.

249 Orafidiya L.O., et al. The effect of aloe vera gel on the antiacne properties of the essential oil of Ocimum gratissimum Linn leaf—–a preliminary clinical investigation. Int J Aromather. 2004;14:15-21.

250 Balambal R., et al. Ocimum basilicum in acne vulgaris—–a controlled comparison with a standard regime. J Assoc Physicians India. 1985;33(8):507-508.

251 Woollard A.C., Tatham K.C., Barker S. The influence of essential oils on the process of wound healing: a review of the current evidence. Wound Care. 2007;16(6):255-257.

252 Hajheydari Z., Jamshidi M., Akbari J., et al. Combination of topical garlic gel and betamethasone valerate cream in the treatment of localised alopecia areata: a double-blind randomised controlled study. Indian J Dermatol Venereol Leprol. 2007;73(1):29-32.

253 Hay I.C., Jamieson M., Ormerod A.D. Randomised trial of aromatherapy. Successful treatment for alopecia areata. Arch Dermatol. 1998;134(11):1349-1352.

254 Butt M.S., Sultan M.T. Green tea: nature’s defense against malignancies. Crit Rev Food Sci Nutr. 2009;49(5):463-473.

255 Rees J.R., Stukel T.A., Perry A.E., et al. Tea consumption and basal cell and squamous cell skin cancer: results of a case-control study. Am Acad Dermatol. 2007;56(5):781-785.

256 Hakim I.A., Harris R.B., Weisgerber U.M. Tea intake and squamous cell carcinoma of the skin: influence of type of tea beverages. Cancer Epidemiol Biomarkers Prev. 2000;9(7):727-731.

257 McNaughton S.A., Marks G.C., Green A.C. Role of dietary factors in the development of basal cell cancer and squamous cell cancer of the skin. Can Epidemiol Biomarkers Prev. 2005;14(7):1596-1607.

258 van Dam R.M., Huang Z., Giovannucci E., et al. Diet and basal cell carcinoma of the skin in a prospective cohort of men. AJCN. 2000;71(1):135-141.

259 Hsu S. Green tea and the skin. J Am Acad Dermatol. 2005;52(6):1049-1059.

260 Ramadan A., Elsaidy M., Zyada R. Effect of low-intensity direct current on the healing of chronic wounds: a literature review. J Wound Care. 2008;17(7):292-296.

261 Olyaee Manesh A., Flemming K., et al. Electromagnetic therapy for treating pressure ulcers. Cochrane Database Syst Rev. (2):2006 Apr 19. CD002930

262 Chen C.J., Yu H.S. Acupuncture, electrostimulation, and reflex therapy in dermatology. Dermatol Ther. 2003;16(2):87-92.

263 Iliev E. Acupuncture in Dermatology. Clinics in Dermatology. 1998;16:659-688.

264 Nie Y., Wang C. A survey of treatment of acne by acupuncture. J Tradit Chin Med. 2008;28(1):71-74.

265 Lihong S. He-Ne laser auricular irradiation plus body acupuncture for treatment of acne vulgaris in 36 cases. J Tradit Chin Med. 2006;26(3):193-194.

266 Liu C.Z., Lei B., Zheng J.F. Randomised control study on the treatment of 26 cases of acne conglobata with encircling acupuncture combined with venesection and cupping. Zhen Ci Yan Jiu. 2008;33(6):406-408.

267 Li B., Chai H., Du Y.H., et al. Evaluation of therapeutic effect and safety for clinical randomised and controlled trials of treatment of acne with acupuncture and moxibustion. Zhongguo Zhen Jiu. 2009;29(3):247-251.

268 Chen C.J., Yu H.S. Acupuncture, electrostimulation, and reflex therapy in dermatology. Dermatol Ther. 2003;16(2):87-92.

269 Lewith G.T., Field J., Machin D. Acupuncture compared with placebo in post-herpetic pain. Pain. 1983;17:361-368.

270 Peng W.N., Liu Z.S., Deng Y.H., et al. Evaluation of literature quality of acupuncture for treatment of herpes zoster and approach to the laws of treatment. Zhongguo Zhen Jiu. 2008;28(2):147-150.

271 Liao S.J., Liao T.A. Acupuncture treatment for psoriasis: a retrospective case report. Acupunct Electrother Res. 1992;17:195-208.

272 Jerner B., Skogh M., Vahlquist A. A controlled trial of acupuncture in psoriasis: no convincing effect. Acta Derm Venereol. 1997;77:154-156.

273 Qing H., Tian Y.S., Fan J.M., et al. Meridian three-combined therapy for treatment of ordinary psoriasis: a multi-center randomised controlled study. Zhongguo Zhen Jiu. 2009;29(3):181-184.

274 Wang D.Z. Indirect moxibustion with herb cake for treatment of atopic dermatitis: dermatitis: 20 cases (in Chinese). China Acupunct. 2000;20:612.

275 Adaskevich V.P. Clinical efficacy and immunoregulatory and neurohumoral effects of MM therapy in patients with atopic dermatitis. Crit Rev Biomed Eng. 2000;28:11-21.

276 Chen C.J., Yu H.S. Acupuncture treatment of urticaria. Arch Dermatol. 1998;134:1397-1399.

277 Jianli C. The effect of acupuncture on serum IgE level in patients with chronic urticaria. J Tradit Chin Med. 2006;26(3):189-190.

278 Zhao Y. Acupuncture plus point-injection for 32 cases of obstinate urticaria. J Tradit Chin Med. 2006;26(1):22-23.

279 Wu C.S., Hu S.C., Lan C.C., et al. Low-energy helium-neon laser therapy induces repigmentation and improves the abnormalities of cutaneous microcirculation in segmental-type vitiligo lesions. Kaohsiung J Med Sci. 2008;24(4):180-189.

280 Millikan L.E. Unapproved Treatments or Indications in Dermatology: Physical Therapy Including Balneotherapy Clinics in Dermatology. 2000;18:125-129.

281 Millikan L.E. Complementary Medicine. Clinics in Dermatology. 2002;20:602-605.

282 Benedetto A.V., Millikan L. Mineral water and spas in the United States. Clin Derm. 1996;14:583-600.

283 Alster T.S., Wanitphakdeedecha R. Improvement of postfractional laser erythema with light-emitting diode photomodulation. Dermatol Surg. 2009;35(5):813-815.

284 Mathur K., Morris S., Deighan C., et al. Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: three case reports and review of literature. J Clin Apher. 2008;23(4):144-150.